<SEC-DOCUMENT>0001193125-17-219691.txt : 20170630
<SEC-HEADER>0001193125-17-219691.hdr.sgml : 20170630
<ACCEPTANCE-DATETIME>20170630152209
ACCESSION NUMBER:		0001193125-17-219691
CONFORMED SUBMISSION TYPE:	PRE 14A
PUBLIC DOCUMENT COUNT:		12
CONFORMED PERIOD OF REPORT:	20170727
FILED AS OF DATE:		20170630
DATE AS OF CHANGE:		20170630

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DYNAVAX TECHNOLOGIES CORP
		CENTRAL INDEX KEY:			0001029142
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				330728374
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PRE 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34207
		FILM NUMBER:		17941869

	BUSINESS ADDRESS:	
		STREET 1:		2929 SEVENTH STREET
		STREET 2:		SUITE 100
		CITY:			BERKELEY
		STATE:			CA
		ZIP:			94710
		BUSINESS PHONE:		5108485100

	MAIL ADDRESS:	
		STREET 1:		2929 SEVENTH STREET
		STREET 2:		SUITE 100
		CITY:			BERKELEY
		STATE:			CA
		ZIP:			94710
</SEC-HEADER>
<DOCUMENT>
<TYPE>PRE 14A
<SEQUENCE>1
<FILENAME>d400617dpre14a.htm
<DESCRIPTION>PRELIMINARY SPECIAL PROXY
<TEXT>
<HTML><HEAD>
<TITLE>PRELIMINARY SPECIAL PROXY</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A
INFORMATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section 14(a) of the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>(Amendment No. &nbsp;&nbsp;&nbsp;&nbsp;) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the
Registrant&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Filed by a Party other than the
Registrant&nbsp;&nbsp;&#9744;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="96%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Preliminary Proxy Statement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Proxy Statement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Additional Materials</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Soliciting Material under &#167;240.14a-12</TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>DYNAVAX
TECHNOLOGIES CORPORATION </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Registrant as Specified In Its Charter) </B></P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
</B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check the appropriate box): </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">No fee required.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">1.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title of each class of securities to which transaction applies:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">2.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aggregate number of securities to which transaction applies:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">3.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing
fee is calculated and state how it was determined):</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">4.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Proposed maximum aggregate value of transaction:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">5.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total fee paid:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee paid previously with preliminary materials.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">6.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amount Previously Paid:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">7.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Form, Schedule or Registration Statement No.:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">8.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filing Party:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">9.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date Filed:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>DYNAVAX TECHNOLOGIES CORPORATION </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">2929 Seventh Street, Suite 100 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Berkeley, California 94710 </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTICE OF SPECIAL MEETING OF STOCKHOLDERS
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>To Be Held On July&nbsp;27, 2017 </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Dear Stockholder: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Notice is hereby given that a Special Meeting of Stockholders
of Dynavax Technologies Corporation, a Delaware corporation (the &#147;Company&#148;), will be held on July&nbsp;27, 2017 at 9:00 a.m. local time at the Company&#146;s executive offices at 2929 Seventh Street, Suite 100, Berkeley, California 94710.
The Company is conducting this Special Meeting for the following purposes: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>To approve an amendment to the Company&#146;s Sixth Amended and Restated Certificate of Incorporation, as amended, to increase the authorized number of shares of
common stock from 69,500,000 to 139,000,000. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>To authorize an adjournment of the meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the Proposal 1; and
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>To transact any other business that may be properly brought before the meeting or any continuation, adjournment or postponement thereof.
</FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As discussed in the proxy statement accompanying this notice, stockholders are being asked to <FONT
STYLE="white-space:nowrap">re-approve</FONT> the amendment to the Company&#146;s Sixth Amended and Restated Certificate of Incorporation, as amended, (the &#147;June Amendment&#148;), which was approved at our 2017 Annual Meeting of Stockholders
held on June&nbsp;2, 2017 (the &#147;Prior Approval&#148;). While we believe the Prior Approval was properly obtained, there may be uncertainty with respect to the validity or effectiveness of the Prior Approval. Specifically, certain shares of
common stock held through brokers/nominees with respect to which no voting instructions were provided, were voted by the broker/nominee in favor of the June Amendment in accordance with the rules of the New York Stock Exchange. Certain statements in
the Company&#146;s definitive proxy statement for the Company&#146;s 2017 Annual Meeting of Stockholders were inconsistent with the treatment of the brokers/nominee votes. The Company corrected this inconsistency by supplemental disclosure on a
Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> prior to the 2017 Annual Meeting of Stockholders following which the matter received the Prior Approval, but there remains uncertainty with respect to the validity or effectiveness
of the Prior Approval. We are resubmitting this same proposal to our shareholders in order to avoid any uncertainty. In resubmitting this proposal to our stockholders at this upcoming meeting, if approved, the effect of this amendment will be to
replace the June Amendment and increase, as in the June amendment which received Prior Approval, the authorized number of shares of common stock from 69,500,000 to 139,000,000.</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The record date for the Special Meeting is June&nbsp;30, 2017. Only stockholders of record at the close of business on that date may vote at the meeting or any adjournment thereof. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1pt;padding-top:2px;padding-bottom:3px">
<P STYLE="margin-top:0px;margin-bottom:0px;padding-top:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Important Notice Regarding the Availability of Proxy Materials for the Stockholders&#146; Meeting to Be Held at 9:00
a.m., Pacific Time, on July&nbsp;27, 2017 at 2929 Seventh Street, Suite 100, Berkeley, California 94710. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px;padding-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The Board of Directors recommends that you vote FOR the proposals identified above. </B></FONT></P></div>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">By Order of the Board of Directors</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Steven N. Gersten</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Secretary</FONT></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Berkeley, California </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">July&nbsp;&nbsp;&nbsp;&nbsp; , 2017 </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1pt;padding-top:2px;padding-bottom:3px">
<P STYLE="margin-top:0px;margin-bottom:4px;padding-top:0px; margin-left:2%;margin-right:2%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>You are cordially invited to attend the meeting in person. Your vote is important,
regardless of the number of shares you own. Whether or not you expect to attend the meeting, please complete, date, sign and return the enclosed proxy as promptly as possible in order to ensure your representation at the meeting. A return envelope
(which is postage prepaid if mailed in the United States) has been provided for your convenience. Even if you have voted by proxy, you may still vote in person if you attend the meeting. Please note, however, that if your shares are held of record
by a broker, bank or other nominee and you wish to vote at the meeting, you must obtain a proxy issued in your name from that record holder. </B></FONT></P>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P></div>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>DYNAVAX TECHNOLOGIES CORPORATION </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">2929 Seventh Street, Suite 100 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Berkeley, California 94710 </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROXY STATEMENT </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>FOR A SPECIAL MEETING OF STOCKHOLDERS </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">July&nbsp;27, 2017 </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Why am I receiving these materials? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We delivered these proxy materials to you because the Board of Directors of Dynavax Technologies Corporation (sometimes referred to as &#147;we,&#148; the &#147;Company&#148; or &#147;Dynavax&#148;) is
soliciting your proxy to vote at a Special Meeting of Stockholders, including at any continuations, adjournments or postponements of the meeting. You are invited to attend the Special Meeting to vote on the proposals described in this proxy
statement. However, you do not need to attend the meeting to vote your shares. Instead, you may simply complete, sign and return the enclosed proxy card. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We intend to mail these proxy materials on or about July&nbsp;10, 2017 to all stockholders of record entitled to vote at the Special Meeting. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>How do I attend the Special Meeting? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The meeting will be held on
July&nbsp;27, 2017 at 9:00 a.m., California time at the Company&#146;s executive offices at 2929 Seventh Street, Suite 100, Berkeley, California 94710. Directions to the Special Meeting may be found at <U>http://www.dynavax.com/contact</U>.
Information on how to vote in person at the Special Meeting is discussed below. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Who can vote at the Special Meeting? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Only stockholders of record at the close of business on June&nbsp;30, 2017 will be entitled to vote at the Special Meeting. On this record
date, there were [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] shares of common stock outstanding and entitled to vote. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>Stockholder of Record: Shares Registered in Your Name </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If on
June&nbsp;30, 2017 your shares were registered directly in your name with the Company&#146;s transfer agent, then you are a stockholder of record. As a stockholder of record, you may vote in person at the meeting or vote by proxy. Whether or not you
plan to attend the meeting, we urge you to fill out and return the enclosed proxy card to ensure your vote is counted. You may still attend the meeting and vote in person even if you have already voted by proxy. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Beneficial Owner: Shares Registered in the Name of a Broker or Bank </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If on June&nbsp;30, 2017 your shares were held, not in your name, but rather in an account at a brokerage firm, bank, dealer, or other
similar organization, then you are the beneficial owner of shares held in &#147;street name&#148; and these proxy materials are being forwarded to you by that organization. The organization holding your account is considered to be the stockholder of
record for purposes of voting at the Special Meeting. As a beneficial owner, you have the right to direct your broker or other agent regarding how to vote the shares in your account. You are also invited to attend the Special Meeting. However, since
you are not the stockholder of record, you may not vote your shares in person at the meeting unless you request and obtain a valid proxy from your broker or other agent. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>What am I voting on? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are asking you to vote on two (2)&nbsp;proposals:
</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 1: To approve an amendment to the Company&#146;s Sixth Amended and Restated Certificate of Incorporation, as amended, to increase the
authorized number of shares of common stock from 69,500,000 to 139,000,000 shares. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 2: To approve the continuation, adjournment or postponement of the Special Meeting for any purpose, including to solicit additional proxies if
there are insufficient votes at the time of the Special Meeting to approve Proposal 1 (this proposal is referred to as the &#147;Adjournment Proposal&#148;). </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Why are we proposing to increase the authorized number of shares of common stock pursuant to Proposal 1? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We desire to have additional shares available to provide additional flexibility to use our capital stock for business and financial purposes in the future. The additional shares may be used for various
purposes without further stockholder approval. These purposes may include raising capital; providing equity incentives to employees, officers or directors; establishing strategic relationships with other companies; expanding our business or product
candidates through the acquisition of other businesses or products; and other purposes related to our business. The additional shares of common stock that would become available for issuance if the proposal were adopted could also be used by us to
oppose a hostile takeover attempt or to delay or prevent changes in control or our management. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Why are we seeking stockholder approval of
the increase in the authorized number of shares of common stock in Proposal 1? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Section&nbsp;242 of the Delaware General
Corporation Law requires stockholder approval of an amendment to our certificate of incorporation, which is required in order to increase the authorized number of shares of our common stock. As discussed above, a substantially similar amendment (the
&#147;June Amendment&#148;) was approved at our 2017 Annual Meeting of Stockholders held on June&nbsp;2, 2017 (the &#147;Prior Approval&#148;). While we believe the Prior Approval was properly obtained, there may be uncertainty with respect to the
validity or effectiveness of the Prior Approval. Specifically, certain shares of common stock held through brokers/nominees and with respect to which the beneficial owner had not provided the broker/nominee with voting instructions, were voted by
the broker/nominee in favor of the June Amendment in accordance with the rules of the New York Stock Exchange. Certain statements explaining the voting standard made in the Company&#146;s definitive proxy statement for the Company&#146;s 2017 Annual
Meeting of Stockholders were inconsistent with this and, therefore, we are seeking stockholder <FONT STYLE="white-space:nowrap">re-approval</FONT> of this amendment. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>What happens if the increase in the authorized number of shares of common stock in Proposal 1 is approved? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">If the increase in the authorized number of shares of our common stock is approved, we will file with the Secretary of State of Delaware a Certificate of Amendment to our Sixth Amended and Restated
Certificate of Incorporation, as amended, to increase our authorized number of shares of common stock from 69,500,000 shares to 139,000,000 shares. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>What happens if the increase in the authorized number of shares of common stock in Proposal 1 is not approved? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">If the increase in the authorized number of shares of our common stock is not approved, our Sixth Amended and Restated Certificate of Incorporation, as amended, will remain as it is, and the authorized
number of shares of our common stock will remain unchanged. Our ability to use our capital stock for business and financial purposes may be limited and we may lose the flexibility to operate our business optimally, including a potential inability to
fund our business and operations in accordance with our strategic plans. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>How do I vote? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">For each of the matters to be voted on, you may vote &#147;For&#148; or &#147;Against&#148; or abstain from voting. The procedures for voting are fairly simple: </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Stockholder of Record: Shares Registered in Your Name </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you are a stockholder of record, you may vote in person at the Special Meeting or vote by proxy using the enclosed proxy card. Whether
or not you plan to attend the meeting, we urge you to vote by proxy to ensure your vote is counted. You may still attend the meeting and vote in person even if you have already voted by proxy. </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">To vote in person, come to the Special Meeting and we will give you a ballot when you arrive. Directions to the Special Meeting location are available
at <U>http://www.dynavax.com/contact</U>. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">To vote using the proxy card, simply complete, sign and date the enclosed proxy card and return it promptly in the envelope provided. If you return
your signed proxy card to us before the Special Meeting, we will vote your shares as you direct. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">To vote using the telephone, simply follow the instructions on the enclosed proxy card. Voting by telephone has the same effect as voting by mail. If
you vote by telephone, do not return your proxy card by mail. You may vote by telephone until 11:59 p.m., Eastern Daylight Time, July&nbsp;26, 2017. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">To vote using the internet, simply follow the instructions on the enclosed proxy card. If you vote by using the internet, do not return your proxy card
by mail. You may vote by using the internet until 11:59 p.m., Eastern Daylight Time, July&nbsp;26, 2017. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Beneficial Owner: Shares Registered in the Name of Broker or Bank </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you are a beneficial owner of shares registered in the name of your broker, bank, or other agent, you should have received a proxy card
and voting instructions with these proxy materials from that organization rather than from Dynavax. Simply complete and mail the proxy card to ensure that your vote is counted. To vote in person at the Special Meeting, you must obtain a valid proxy
from your broker, bank, or other agent. Follow the instructions from your broker or bank included with these proxy materials, or contact your broker or bank to request a proxy form. Brokers and nominees are able to use their discretion to vote
&#147;unrestricted&#148; shares with respect to matters that are considered to be &#147;routine,&#148; but not with respect to <FONT STYLE="white-space:nowrap">&#147;non-routine&#148;</FONT> matters. Typically, when brokers vote on
&#147;routine&#148; matters, they vote in favor of the matter. We believe that both proposals are &#147;routine&#148; matters. Thus, brokers and nominees may vote on each of the two proposals for which we seek approval, without first receiving your
instructions to do so. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1pt;padding-top:2px;padding-bottom:3px">
<P STYLE="margin-top:0px;margin-bottom:0px;padding-top:0px; margin-left:2%;margin-right:2%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>We provide internet proxy voting to allow you to vote your shares online, with
procedures designed to ensure the authenticity and correctness of your proxy vote instructions. However, please be aware that you must bear any costs associated with your internet access, such as usage charges from internet access providers and
telephone companies. </B></FONT></P></div> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>How many votes do I have? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">On each matter to be voted upon, you have one vote for each share of common stock you own as of June&nbsp;30, 2017. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>What if I return a proxy card or otherwise vote but do not make specific choices? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">If you return a signed and dated proxy card or otherwise vote without marking voting selections, your shares will be voted &#147;For&#148; the approval of the amendment to our Sixth Amended and Restated
Certificate of Incorporation, as amended, to increase the authorized number of shares of our common stock. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Who is paying for this proxy solicitation? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We will pay for the entire cost of soliciting proxies. In addition to these proxy materials, our directors and employees may also solicit
proxies in person, by telephone, or by other means of communication. Directors and employees will not be paid any additional compensation for soliciting proxies. We may also reimburse brokerage firms, banks and other agents for the cost of
forwarding proxy materials to beneficial owners. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>What does it mean if I receive more than one set of proxy materials? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you receive more than one set of proxy materials, your shares may be registered in more than one name or in different accounts. Please
follow the voting instructions on the proxy cards in the proxy materials to ensure that all of your shares are voted. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Can I change my vote
after submitting my proxy? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Yes. You can revoke your proxy at any time before the final vote at the meeting. If you are the
record holder of your shares, you may revoke your proxy in any one of the following ways: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">You may submit another properly completed proxy card with a later date. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">You may send a timely written notice that you are revoking your proxy to Dynavax&#146;s Secretary at 2929 Seventh Street, Suite 100, Berkeley,
California 94710. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">You may attend the Special Meeting and vote in person. Simply attending the meeting will not, by itself, revoke your proxy.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Your most current proxy card or telephone or internet proxy is the one that is counted. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If your shares are held by your broker or bank as a nominee or agent, you should follow the instructions provided by your broker or bank.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>How are votes counted? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Votes will be counted by the inspector of election appointed for the meeting, who will separately count &#147;For&#148; and &#147;Against&#148; votes, abstentions and broker
<FONT STYLE="white-space:nowrap">non-votes,</FONT> if any. Abstentions will be counted towards the vote total for each proposal, and will have the same effect as &#147;Against&#148; votes. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>What are &#147;broker <FONT STYLE="white-space:nowrap">non-votes&#148;</FONT> and what is their effect on the vote? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Broker <FONT STYLE="white-space:nowrap">non-votes</FONT> occur when a beneficial owner of shares held in &#147;street name&#148; fails to provide instructions to the broker or nominee holding the shares
as to how to vote on matters deemed <FONT STYLE="white-space:nowrap">&#147;non-routine.&#148;</FONT> If the beneficial owner does not provide voting instructions, the broker or nominee cannot vote the shares with respect to <FONT
STYLE="white-space:nowrap">&#147;non-routine&#148;</FONT> matters, but can vote the shares with respect to &#147;routine&#148; matters. Typically, when brokers are able to vote the shares, they vote in favor of the matter. We believe both proposals
are &#147;routine&#148; matters and, as a result, we do not expect there to be any broker <FONT STYLE="white-space:nowrap">non-votes.</FONT> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">As long as one of the matters is deemed to be a &#147;routine&#148; matter, proxies reflecting broker <FONT STYLE="white-space:nowrap">non-votes</FONT> (if any) will be counted towards the quorum
requirement. On Proposal 1, broker <FONT STYLE="white-space:nowrap">non-votes</FONT> (if any) will have the same effect as &#147;Against&#148; votes, and Proposal 2, broker <FONT STYLE="white-space:nowrap">non-votes</FONT> (if any) will have no
effect. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Whether a matter is &#147;routine&#148; or not is ultimately up to the New York Stock Exchange, and the New York
Stock Exchange may make a determination that is different from what we believe to be the case. If that occurs, brokers may be able to vote your shares on matters we believe to be not routine, or not vote your shares on matters that we believe to be
routine. Accordingly, we strongly encourage you to submit your proxy and exercise your right to vote as a stockholder to insure that your shares are voted in the manner in which you want them to be voted. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">4 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>How many votes are needed to approve each proposal? </B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 1, to approve the amendment of the Company&#146;s Sixth Amended and Restated Certificate of Incorporation, as amended, to increase the
authorized number of shares of common stock from 69,500,000 to 139,000,000 shares, must receive &#147;For&#148; votes from the holders of a majority of the Company&#146;s outstanding shares entitled to vote. If you fail to return your proxy card, it
will have the same effect as an &#147;Against&#148; vote. If you return your proxy card and select &#147;Abstain,&#148; it will have the same effect as an &#147;Against&#148; vote. Broker <FONT STYLE="white-space:nowrap">non-votes</FONT> (if any)
will have the same effect as &#147;Against&#148; votes. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 2, to approve the continuation, adjournment or postponement of the Special Meeting for any purpose, including to solicit additional proxies if
there are insufficient votes at the time of the Special Meeting to approve Proposal 1, must receive &#147;For&#148; votes from the holders of a majority of shares present either in person or by proxy, if a quorum of stockholders is achieved. If you
return your proxy and select &#147;Abstain,&#148; it will have the same effect as an &#147;Against&#148; vote. Broker <FONT STYLE="white-space:nowrap">non-votes</FONT> (if any) will have no effect. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>What is the quorum requirement? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">A quorum of stockholders is necessary to hold a valid meeting. A quorum will be present if stockholders holding at least a majority of the outstanding shares entitled to vote are present at the meeting in
person or represented by proxy. On the record date, there were [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] shares outstanding and entitled to vote. Thus, the holders of at least
[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] shares must be present in person or represented by proxy at the meeting to have a quorum. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Your shares will be counted towards the quorum only if you submit a valid proxy (or one is submitted on your behalf by your broker, bank or other nominee) or if you vote in person at the meeting.
Abstentions and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will be counted towards the quorum requirement. If there is no quorum, the holders of a majority of shares present at the meeting in person or represented by proxy may adjourn
the meeting to another date. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>How does Dynavax&#146;s Board of Directors recommend that I vote? </B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">After careful consideration, our Board of Directors has approved the amendment to our Sixth Amended and Restated Certificate of Incorporation, as
amended, to increase the number of authorized shares of our common stock, and has determined that such action is advisable and in the best interests of Dynavax and our stockholders. Accordingly, our Board of Directors recommends that Dynavax
stockholders vote &#147;For&#148; Proposal 1. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">After careful consideration, our Board of Directors has determined that Proposal 2 regarding adjournment to solicit additional proxies is advisable and
in the best interests of Dynavax and our stockholders. Accordingly, our Board of Directors recommends that Dynavax stockholders vote &#147;For&#148; Proposal 2. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Am I entitled to appraisal rights? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under Delaware law, Dynavax
stockholders are not entitled to appraisal rights in connection with the transactions described in this proxy statement. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>How can I find
out the results of the voting at the Special Meeting? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Preliminary voting results will be announced at the Special Meeting.
Final voting results will be published in a current report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> that we expect to file within four business days after the Special Meeting. If final voting results are not available to us in time to
file a Form <FONT STYLE="white-space:nowrap">8-K</FONT> within four business days after the meeting, we intend to file a Form <FONT STYLE="white-space:nowrap">8-K</FONT> to publish preliminary results and, within four business days after the final
results are known to us, file an additional Form <FONT STYLE="white-space:nowrap">8-K</FONT> to publish the final results. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">5 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>What proxy materials are available on the internet? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The proxy statement is available at [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>When are stockholder proposals due for next year&#146;s annual meeting? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">To be considered for inclusion in next year&#146;s proxy materials, your proposal must be submitted in writing by December&nbsp;27, 2017 to Dynavax Technologies Corporation, Attention: Corporate
Secretary, 2929 Seventh Street, Suite 100, Berkeley, California 94710. However, if our 2018 Annual Meeting of Stockholders is not held between May&nbsp;1, 2018, and June&nbsp;30, 2018, then the deadline will be a reasonable time before we begin to
print and send our proxy materials. If you wish to submit a proposal (including a director nomination) that is not to be included in next year&#146;s proxy materials or nominate a director, you must do so no later than April&nbsp;1, 2018, and no
earlier than March&nbsp;2, 2018. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">6 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROPOSAL 1 </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>APPROVAL OF AN AMENDMENT TO THE SIXTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION, AS AMENDED, TO INCREASE THE AUTHORIZED NUMBER OF SHARES OF </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>COMMON STOCK FROM 69,500,000 TO 139,000,000 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Board is requesting stockholder approval of an amendment to the Company&#146;s Sixth Amended and Restated Certificate of Incorporation, as amended (the &#147;Charter&#148;), to increase the authorized
number of the Company&#146;s shares of common stock from 69,500,000 to 139,000,000 shares (the &#147;Charter Amendment&#148;). This description is qualified by the full text of the Charter Amendment that is attached as Appendix A to this proxy
statement. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Background </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">At our 2017 Annual Meeting of Stockholders held on June&nbsp;2, 2017, we sought stockholder approval of an amendment to the Company&#146;s Sixth Amended and Restated Certificate of Incorporation, as
amended, to the increase the authorized number of shares of common stock from 69,500,000 to 139,000,000 (the &#147;Prior Proposal&#148;). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">At our 2017 Annual Meeting of Stockholders, our inspector of elections determined that the Prior Proposal received the requisite stockholder approval and certified that the Prior Proposal passed. As part
of this determination, votes cast by brokers/nominees without instruction from the beneficial owners of certain of our outstanding shares were counted in favor of the Prior Proposal in accordance with the rules of the New York Stock Exchange that
govern how brokers may cast such votes. Certain statements made in the definitive proxy statement for the 2017 Annual Meeting of Stockholders, which was filed on Schedule 14A with the SEC on April&nbsp;21, 2017 (the &#147;2017 Proxy
Statement&#148;), were inconsistent with this approach.&nbsp;The 2017 Proxy Statement stated that brokers/nominees would not have discretion to vote for the proposal to approve the Prior Proposal without instruction, and that broker <FONT
STYLE="white-space:nowrap">non-votes</FONT> would be counted &#147;against&#148; the proposal. We supplemented the 2017 Proxy Statement in a filing on a Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> on May&nbsp;30, 2017 in order
to clarify the voting requirements and adjourned our 2017 Annual Meeting of Stockholders to allow our beneficial owners to instruct their broker, bank, or other agent how to vote their shares, and confirmed that brokers and nominees can use their
discretion to vote &#147;uninstructed&#148; (the &#147;Supplemental Disclosure&#148;). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our independent inspector of elections
for the 2017 Annual Meeting of Stockholders certified that the Prior Proposal passed. We subsequently filed a Certificate of Amendment with the Secretary of State of the State of Delaware on&nbsp;June 2, 2017. Notwithstanding the Supplemental
Disclosure,&nbsp;the Board of Directors, in consultation with counsel, has determined that the description of the authority of brokers and nominees to vote, including the voting standard with respect to any of such votes, on the Prior Proposal
without instruction in the original 2017 Proxy Statement may create some uncertainty as to the effect of the vote obtained at the 2017 Annual Meeting of Stockholders. As a result, the Board of Directors has determined that it is in the best
interests of the Company and our stockholders to ask our stockholders to approve the Charter Amendment again at this Special Meeting in order to eliminate any uncertainty related to the effectiveness of these corporate acts. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Proposal </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The additional common stock to be authorized by adoption of the amendment would have rights identical to the currently outstanding common stock of the Company. Stockholders have no preemptive rights to
acquire shares of common stock issued by the Company under its Charter. This means that current stockholders do not have a prior right to purchase any new issue of our capital stock in order to maintain their proportionate ownership of common stock.
Adoption of the proposed amendment and issuance of the common stock would not affect the rights of the holders of currently outstanding common stock of the Company, except for effects incidental to increasing the number of shares of the
Company&#146;s common stock outstanding, such as dilution of the earnings per share and voting rights of current holders of common stock. The issuance of additional shares of our common stock, or the perception that additional shares may be issued,
may adversely affect the market price of our common stock. The additional </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">7 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
shares of common stock authorized by the approval of this Proposal 1 could be issued by our Board without further vote of our stockholders except as may be required in particular cases by our
Charter, applicable law, regulatory agencies or the rules of the NASDAQ Stock Market. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition to the
[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] shares of common stock outstanding on June&nbsp;30, 2017, there were: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] shares of common stock reserved for future issuance under the Company&#146;s
2004 Stock Incentive Plan; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] shares of common stock reserved for future issuance under the Company&#146;s
2010 Employment Inducement Plan; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] shares of common stock reserved for future issuance under the Company&#146;s
Amended 2011 Equity Incentive Plan, which may be further amended upon approval of Proposal 2; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] shares of common stock reserved for future issuance under the Company&#146;s
Amended and Restated 2014 Employee Stock Purchase Plan. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Additionally, as of June&nbsp;30, 2017, no shares
of preferred stock were outstanding. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have financed our operations and internal growth primarily through public offerings
and private placements of our common stock and funding from collaborations and government grants. We do not currently have any commitments for future external funding and, until we can generate a sufficient amount of product revenue, which we may
never do, we expect to finance future cash needs through one or more of the following: public or private equity offerings; debt financings; collaboration and licensing arrangements, which often involve the possibility of an equity investment; and
interest income earned on the investment of our cash and short-term investments. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Although the Board has no immediate plans to
issue the additional shares of common stock it desires to have the shares available to provide additional flexibility to use its common stock for business and financial purposes in the future as well to have sufficient shares available to provide
appropriate equity incentives for our employees. The additional shares may be used for various purposes without further stockholder approval. These purposes may include raising capital; providing equity incentives to employees, officers, directors,
consultants and/or advisors; establishing strategic relationships with other companies; expanding our business through the acquisition of other businesses, products or technologies; and other purposes. For example, we will need to raise substantial
additional funds to, among other things, finance our operations, clinical trials and the initial commercial activities for our product <FONT STYLE="white-space:nowrap">HEPLISAV-B&#153;,</FONT> if it is approved. In addition, in view of the recently
reported positive results in our lead oncology program, we anticipate we will continue to require additional capital to conduct later stage clinical trials. Thus, we will need to obtain significant amounts of additional capital and the additional
shares may be used for a financing if we have an appropriate opportunity. Although we may pursue other sources of funding, such as corporate collaborations and partnerships, if we are not successful with these efforts or if our Board otherwise
determines that a financing through issuing additional shares is attractive, we want to be in a position to act quickly depending on market conditions. If this Proposal 1 is not approved by our stockholders, it is possible that financing
alternatives for the Company may be limited by the lack of sufficient unissued and unreserved authorized shares of common stock, and stockholder value may be harmed by this limitation. In addition, our success depends in part on our continued
ability to attract, retain and motivate highly qualified management and clinical and scientific personnel, and if this Proposal 1 is not approved by our stockholders, the lack of sufficient unissued and unreserved authorized shares of common stock
to provide future equity incentive opportunities the Compensation Committee of our Board deems appropriate could adversely impact our ability to achieve these goals. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">If our stockholders do not approve this Proposal 1, we may not be able to access the capital markets; complete corporate collaborations or partnerships; attract, retain and motivate employees; or pursue
other business opportunities integral to our growth and success. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Board believes that the proposed increase in authorized
common stock will make sufficient shares available to provide the additional flexibility necessary to pursue our strategic objectives. Over the past several </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">8 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
years, flexibility has allowed us to pursue a number of strategic and financing transactions. For example, in 2015, we issued an aggregate of 7,352,712 shares of our common stock in an
underwritten public offering and through an At The Market Agreement for gross proceeds of approximately $194&nbsp;million to fund clinical development and other research and development activities and for working capital and general corporate
purposes. As of June&nbsp;15, 2017, we have sold 15,997,202 shares of our common stock through an At The Market Agreement for net proceeds of approximately $88.2&nbsp;million. Unless our stockholders approve this Proposal&nbsp;1, we will not have
sufficient unissued and unreserved authorized shares of common stock to engage in similar transactions or to meet exigent needs to implement new or revised equity compensation arrangements in the future. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The proposed amendment to our Amended and Restated Certificate of Incorporation to increase the number of authorized shares of our common
stock could, under certain circumstances, have an anti-takeover effect. The additional shares of common stock that would become available for issuance if this Proposal 1 is approved could also be used by us to oppose a hostile takeover attempt or to
delay or prevent changes in control or our management of the Company. For example, pursuant to our current Rights Agreement, dated November&nbsp;5, 2008, between the Company and Mellon Investor Services LLC under certain circumstances related to an
acquisition of shares via a tender or exchange offer whereby a person becomes the beneficial owner of 20% or more of our common stock in a transaction not approved by the Board, Preferred Shares could be issued to our current stockholders upon the
exercise of the Rights. Additionally, without further stockholder approval, the Board could strategically sell shares of common stock in a private transaction to purchasers who would oppose a takeover or favor the current Board. Although this
proposal to increase the authorized common stock has been prompted by business and financial considerations and not by the threat of any hostile takeover attempt (nor is the Board currently aware of any such attempts directed at us), nevertheless,
stockholders should be aware that approval of this Proposal&nbsp;1 could facilitate future efforts by us to deter or prevent changes in control of the Company, including transactions in which the stockholders might otherwise receive a premium for
their shares over then current market prices. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the amendment is adopted, it will become effective upon filing of a
Certificate of Amendment of the Company&#146;s Charter with the Secretary of State of the State of Delaware and the authorized shares would be available for issuance. No further stockholder authorization would be required prior to the issuance of
such shares by the Company, except where stockholder approval is required under Delaware corporate law or NASDAQ rules. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Vote Required;
Recommendation of the Board of Directors </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The affirmative vote of the holders, cast either in person or by proxy, of a
majority of the outstanding shares will be required to approve this Proposal 1. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>T<SMALL>HE</SMALL>&nbsp;B<SMALL>OARD</SMALL>&nbsp;O<SMALL>F</SMALL>&nbsp;D<SMALL>IRECTORS</SMALL>&nbsp;R<SMALL>ECOMMENDS</SMALL>
</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A
V<SMALL>OTE</SMALL>&nbsp;I<SMALL>N</SMALL>&nbsp;F<SMALL>AVOR</SMALL>&nbsp;O<SMALL>F</SMALL>&nbsp;P<SMALL>ROPOSAL</SMALL>&nbsp;1. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">9 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROPOSAL 2 </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>AUTHORIZATION TO ADJOURN THE SPECIAL MEETING </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>General </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the Special Meeting is convened and a quorum is present, but there are not sufficient votes to approve Proposal 1, our proxy holders
may move to continue, adjourn or postpone the Special Meeting at that time in order to enable the our board of directors to solicit additional proxies. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In this proposal, we are asking our stockholders to authorize the holder of any proxy solicited by our board of directors to vote in favor of granting discretionary authority to the proxy holders, and
each of them individually, to adjourn the Special Meeting to another time and place, if necessary, to solicit additional proxies in the event there are not sufficient votes to approve Proposal 1. If our stockholders approve this proposal, we could
continue, adjourn or postpone the Special Meeting and any continued, adjourned or postponed session of the Special Meeting and use the additional time to solicit additional proxies, including the solicitation of proxies from our stockholders that
have previously voted. Among other things, approval of this proposal could mean that, even if we had received proxies representing a sufficient number of votes to defeat Proposal 1, we could continue, adjourn or postpone the Special Meeting without
a vote on such proposal and seek to convince our stockholders to change their votes in favor of such proposal. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If it is
necessary to continue, adjourn or postpone the Special Meeting, no notice of the continued, adjourned or postponed meeting is required to be given to our stockholders, other than an announcement at the Special Meeting of the time and place to which
the Special Meeting is continued, adjourned or postponed, so long as the meeting is continued, adjourned or postponed for 30 days or less and no new record date is fixed for the continued, adjourned or postponed meeting. At the continued, adjourned
or postponed meeting, we may transact any business which might have been transacted at the original meeting. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Vote Required; Recommendation
of the Board of Directors </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Approval of the Adjournment Proposal requires &#147;FOR&#148; votes from the holders of a
majority of shares of our Common Stock present or represented at the Special Meeting and entitled to vote. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>T<SMALL>HE</SMALL>&nbsp;B<SMALL>OARD</SMALL>&nbsp;O<SMALL>F</SMALL>&nbsp;D<SMALL>IRECTORS</SMALL>&nbsp;R<SMALL>ECOMMENDS</SMALL>
</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A
V<SMALL>OTE</SMALL>&nbsp;I<SMALL>N</SMALL>&nbsp;F<SMALL>AVOR</SMALL>&nbsp;O<SMALL>F</SMALL>&nbsp;P<SMALL>ROPOSAL</SMALL>&nbsp;2. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SECURITY OWNERSHIP OF </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>CERTAIN BENEFICIAL OWNERS AND MANAGEMENT </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth certain information regarding the ownership of the Company&#146;s common stock as of June&nbsp;15, 2017 by: (i)&nbsp;each director; (ii)&nbsp;the NEOs; (iii)&nbsp;all
executive officers and directors of the Company as a group; and (iv)&nbsp;all those known by the Company to be beneficial owners of more than five percent of its common stock. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="76%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:135pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name and Address of Beneficial Holder</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Shares<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)
</SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Percent&nbsp;of&nbsp;Shares<BR>Beneficially<BR>Owned<SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3) </SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5% Stockholders:</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Federated Investors, Inc.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4) </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,619,173</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.61</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Federated Investors Tower</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pittsburgh, Pennsylvania 15222-3779</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:76pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>NEOs and Directors<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)
</SUP></B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Eddie Gray</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5) </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">663,071</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael S. Ostrach</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6) </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">209,463</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Robert L. Coffman, Ph.D.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7) </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">194,090</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Robert Janssen, M.D.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(8) </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">127,713</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">David F. Novack</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(9) </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">131,632</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Arnold L. Oronsky, Ph.D.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(10) </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">74,956</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Laura Brege</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(11) </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19,175</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Francis R. Cano, Ph.D.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(12) </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">38,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dennis A. Carson, M.D.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(13) </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">34,062</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Daniel L. Kisner, M.D.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(14) </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">37,450</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peggy V. Phillips</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(15) </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">51,252</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stanley A. Plotkin, M.D.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(16) </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Natale Ricciardi</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(17) </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All executive officers and directors as a group (13 persons)</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(18) </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,629,114</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.89</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Less than one percent. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">The address of each of the NEOs and directors is c/o Dynavax Technologies Corporation, 2929 Seventh Street, Suite 100, Berkeley, California 94710.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">To our knowledge, except as set forth in the footnotes to this table, and subject to applicable community property laws, each person named in this
table has sole voting and investment power with respect to the shares set forth opposite such person&#146;s name. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to the
securities. Shares of our common stock subject to options currently exercisable or that will become exercisable within 60 days after June&nbsp;15, 2017, are deemed outstanding for computing the percentage of the person holding such options but are
not deemed outstanding for computing the percentage of any other person. Applicable percentages are based on 54,747,656 shares of our common stock outstanding as of June&nbsp;15, 2017, adjusted as required by the rules of the SEC.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">This information is based solely on a Schedule 13G/A filed by Federated Investors, Inc., on February&nbsp;14, 2017, with the SEC. Federated Investors,
Inc. (the &#147;Parent&#148;) is the parent holding company of Federated Equity Management Company of Pennsylvania and Federated Global Investment Management Corp. (the &#147;Investment Advisers&#148;), which act as investment advisers to registered
investment companies and separate accounts that own shares of common stock. The Investment Advisers are wholly owned subsidiaries of FII Holdings, Inc., which is wholly owned subsidiary of the Parent. All of the Parent&#146;s outstanding voting
stock is held in the Voting Shares Irrevocable Trust (the &#147;Trust&#148;) for which John F. Donahue, Rhodora J. Donahue and J. Christopher Donahue act as trustees (collectively, the &#147;Trustees&#148;). The Parent and the Trust each have sole
voting power over all 3,619,173 shares of common stock. The Trustees have joined in filing the Schedule 13G because of the collective voting control that they exercise over the Parent. In accordance with Rule
<FONT STYLE="white-space:nowrap">13d-4</FONT> under the Securities Act of 1934, as amended, the Parent, the Trust, and each of the Trustees declare that this statement should not be construed as an admission that they are the beneficial owners, and
the Parent, the Trust, and each of the Trustees expressly disclaim beneficial ownership. The address of the principal business and office of Federated Investors, Inc. and its affiliates is Federated Investors Towers, Pittsburgh, PA 15222-3779. The
Schedule 13G/A provides information only as of December&nbsp;31, 2016, and, consequently, the beneficial ownership of the above-mentioned reporting person may have changed between December&nbsp;31, 2016 and June&nbsp;15, 2017.
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">11 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Consists of 35,573 shares of common stock owned directly by Mr.&nbsp;Gray and options to purchase 627,498 shares of common stock exercisable within 60
days of June&nbsp;15, 2017. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Consists of 14,646 shares of common stock owned directly by Mr.&nbsp;Ostrach and options to purchase 194,817 shares of common stock exercisable within
60 days of June&nbsp;15, 2017. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Consists of 6,308 shares of common stock owned directly by Dr.&nbsp;Coffman and options to purchase 187,782 shares of common stock exercisable within
60 days of June&nbsp;15, 2017. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(8)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Consists of 24,548 shares of common stock owned directly by Dr.&nbsp;Janssen, 948 of which were purchased through the employee stock purchase plan and
options to purchase 103,165 shares of common stock exercisable within 60 days of June&nbsp;15, 2017. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(9)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Consists of 14,174 shares of common stock owned directly by Mr.&nbsp;Novack, 1,671 of which were purchased through the employee stock purchase plan and
options to purchase 117,458 shares of common stock exercisable within 60 days of June&nbsp;15, 2017. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(10)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Consists of 37,506 shares of common stock owned directly by Dr.&nbsp;Oronsky and options to purchase 37,450 shares of common stock exercisable within
60 days of June&nbsp;15, 2017. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(11)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Consists of options to purchase 19,175 shares of common stock exercisable within 60 days of June&nbsp;15, 2017. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(12)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Consists of 6,200 shares of common stock owned directly by Dr.&nbsp;Cano and options to purchase 32,550 shares of common stock exercisable within 60
days of June&nbsp;15, 2017. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(13)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Consists of 6,812 shares of common stock owned directly by Dr.&nbsp;Carson and options to purchase 27,250 shares of common stock exercisable within 60
days of June&nbsp;15, 2017. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(14)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Consists of 1,500 shares of common stock owned directly by Dr.&nbsp;Kisner and options to purchase 35,950 shares of common stock exercisable within 60
days of June&nbsp;15, 2017. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(15)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Consists of 13,802 shares of common stock owned directly by Ms.&nbsp;Phillips and options to purchase 37,450 shares of common stock exercisable within
60 days of June&nbsp;15, 2017. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(16)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Consists of 1,000 shares of common stock owned directly by Dr.&nbsp;Plotkin and options to purchase 26,250 shares of common stock exercisable within 60
days of June&nbsp;15, 2017. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(17)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Consists of options to purchase 20,250 shares of common stock exercisable within 60 days of June&nbsp;15, 2017. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(18)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Total number of shares includes 162,069 shares of common stock in aggregate held as of June&nbsp;15, 2017, by our executive officers and directors and
entities affiliated with such executive officers and directors and options to purchase 1,467,045 shares of common stock exercisable within 60 days of June&nbsp;15, 2017. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Additional Information About Us </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dynavax electronically files annual,
quarterly and current reports, proxy statements and other information with the SEC. The SEC maintains a website that contains reports, proxy and information statements and other information regarding Dynavax and other issuers that file
electronically with the SEC at www.sec.gov. The Company&#146;s annual reports on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> quarterly reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> and current reports on Form <FONT
STYLE="white-space:nowrap">8-K,</FONT> as well as any amendments to those reports, are available free of charge through the SEC&#146;s website. Stockholders may also read and copy materials that Dynavax files with the SEC at the SEC&#146;s Public
Reference Room at 450 Fifth Street, NW, Washington, DC 20549. Stockholders may obtain information on the operation of the Public Reference Room by calling the SEC at <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">1-800-SEC-0330.</FONT></FONT></FONT> </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">12 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>HOUSEHOLDING OF PROXY MATERIALS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Securities and Exchange Commission, or SEC, has adopted rules that permit companies and intermediaries (e.g., brokers) to satisfy the
delivery requirements for Special Meeting materials with respect to two or more stockholders sharing the same address by delivering a single set of Special Meeting materials addressed to those stockholders. This process, which is commonly referred
to as &#147;householding,&#148; potentially means extra convenience for stockholders and cost savings for companies. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A number
of brokers with account holders who are Dynavax stockholders will be &#147;householding&#148; our proxy materials. A single set of Special Meeting materials will be delivered to multiple stockholders sharing an address unless contrary instructions
have been received from the affected stockholders. Once you have received notice from your broker that they will be &#147;householding&#148; communications to your address, &#147;householding&#148; will continue until you are notified otherwise or
until you revoke your consent. If, at any time, you no longer wish to participate in &#147;householding&#148; and would prefer to receive a separate set of Special Meeting materials, please notify your broker and we will promptly deliver to you a
separate set of our Special Meeting materials. Direct your written request to Dynavax Technologies Corporation, Attention: Corporate Secretary, 2929 Seventh Street, Suite 100, Berkeley, California 94710,
<FONT STYLE="white-space:nowrap">(510)&nbsp;848-5100.</FONT> Stockholders who currently receive multiple copies of the Special Meeting materials at their addresses and would like to request &#147;householding&#148; of their communications should
contact their brokers. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">13 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>OTHER MATTERS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors knows of no other matters that will be presented for consideration at the Special Meeting. If any other matters
are properly brought before the meeting, it is the intention of the persons named in the accompanying proxy to vote on such matters in accordance with their best judgment. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">By Order of the Board of Directors</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT><FONT SIZE="">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Steven N. Gersten</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Secretary</FONT></P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">July&nbsp;&nbsp;&nbsp;&nbsp;, 2017 </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">14 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Annex A </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>CERTIFICATE OF AMENDMENT OF THE </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SIXTH AMENDED AND RESTATED CERTIFICATE
OF INCORPORATION OF </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>DYNAVAX TECHNOLOGIES CORPORATION </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>DYNAVAX TECHNOLOGIES CORPORATION</B>, a corporation organized and existing under and by virtue of the General Corporation Law of the
State of Delaware (the &#147;<B><I>Corporation</I></B>&#148;), hereby certifies that: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>FIRST</B>: The name of the
Corporation is<B>&nbsp;DYNAVAX TECHNOLOGIES CORPORATION</B> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SECOND</B>: The Corporation was originally incorporated under
the same name and the original Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on November&nbsp;6, 2000. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>THIRD</B>: The Board of Directors of the Corporation, acting in accordance with the provisions of Sections&nbsp;141 and 242 of the General Corporation Law of the State of Delaware, adopted resolutions
to amend its Sixth Amended and Restated Certificate of Incorporation as follows: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">1. Article IV shall be amended and restated
to read in its entirety as follows: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;The Corporation is authorized to issue two classes of stock to be designated,
respectively, Common Stock and Preferred Stock. The Corporation shall be authorized to issue 139,000,000 shares of Common Stock at $0.001 par value, and 5,000,000 shares of Preferred Stock at $0.001 par value. The Preferred Stock may be issued from
time to time in one or more series pursuant to a resolution or resolutions providing for such issue duly adopted by the Board of Directors (authority to do so being hereby expressly vested in the Board). The rights, preferences, privileges and
restrictions granted to or imposed upon the Preferred Stock or any series of Preferred Stock will be determined or altered by the Board of Directors. The Board of Directors shall also have the authority to fix or alter the number of shares of any
series of Preferred Stock and the designation of any such series of Preferred Stock. The Board of Directors, within the limits and restrictions stated in any resolution or resolutions of the Board of Directors originally fixing the number of shares
constituting any series, may increase or decrease (but not below the number of shares in any such series then outstanding), the number of shares of any series subsequent to the issue of shares of that series.&#148; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>FOURTH:</B>&nbsp;Thereafter pursuant to a&nbsp;resolution of the Board of Directors, this Certificate of Amendment was submitted to
the stockholders of the Corporation for their approval, and was duly adopted at the Special Meeting of Stockholders held on July&nbsp;27, 2017 in accordance with the provisions of Section&nbsp;242 of the General Corporation Law of the State of
Delaware. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>IN WITNESS WHEREOF</B>, the Corporation has caused this Certificate of Amendment to be signed by its Chief
Executive Officer this [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] day of [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], 2017. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>DYNAVAX TECHNOLOGIES CORPORATION</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">By:</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Eddie Gray, Chief Executive Officer</FONT></TD></TR>
</TABLE></DIV>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="54%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="36%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">


<IMG SRC="g400617img2.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:1pt" ALIGN="right">


<IMG SRC="g400617img3.jpg" ALT="LOGO">
</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em" ALIGN="right">


<IMG SRC="g400617img1.jpg" ALT="LOGO">
&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>VOTE BY INTERNET - www.proxyvote.com</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 P.M. Eastern Time the day before the <FONT
STYLE="white-space:nowrap">cut-off</FONT> date or meeting date. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form.</P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">If you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards
and annual reports electronically via <FONT STYLE="white-space:nowrap">e-mail</FONT> or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the Internet and, when prompted, indicate that you agree to
receive or access proxy materials electronically in future years.</P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>VOTE BY PHONE - <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-690-6903</FONT></FONT></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Use any touch-tone telephone to transmit your voting
instructions up until 11:59 P.M. Eastern Time the day before the <FONT STYLE="white-space:nowrap">cut-off</FONT> date or meeting date. Have your proxy card in hand when you call and then follow the instructions.</P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>VOTE BY MAIL</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes
Way, Edgewood, NY 11717.</P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em" ALIGN="center">


<IMG SRC="g400617img4.jpg" ALT="LOGO">
</P></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="68%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="30%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9746;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">KEEP THIS PORTION FOR YOUR RECORDS</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;
&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp; &#151;&nbsp;&#151;&nbsp; &#151;&nbsp;&#151;&nbsp;&#151;&nbsp;
&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;
&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;
</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="right"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">DETACH&nbsp;AND&nbsp;RETURN&nbsp;THIS&nbsp;PORTION&nbsp;ONLY</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="24%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1.00pt solid #000000; BORDER-TOP:1.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1.00pt solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1.00pt solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1.00pt solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1.00pt solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1.00pt solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1.00pt solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1.00pt solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1.00pt solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1.00pt solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="9" ALIGN="right" STYLE="BORDER-TOP:1.00pt solid #000000; BORDER-RIGHT:1.00pt solid #000000">


<IMG SRC="g400617img5.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD ROWSPAN="2" VALIGN="bottom"> <P STYLE="margin-bottom:1pt; margin-top:0pt">&nbsp;</P></TD>
<TD ROWSPAN="2" VALIGN="bottom"> <P STYLE="margin-bottom:1pt; margin-top:0pt" ALIGN="right">


<IMG SRC="g400617img8.jpg" ALT="LOGO">
</P></TD>
<TD ROWSPAN="2" NOWRAP VALIGN="bottom"> <P STYLE="margin-bottom:1pt; margin-top:0pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="7"> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>The Board of Directors recommends you vote FOR proposals
1, 2 and 3.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>For</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>Against</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1.00pt solid #000000"><B>Abstain</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ROWSPAN="6"> <P STYLE="margin-top:0pt;margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em">


<IMG SRC="g400617img9.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="15"> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Times New Roman"><B>1.</B>&nbsp;&nbsp;&nbsp;To approve an amendment to the Company&#146;s Sixth Amended and Restated Certificate of
Incorporation, as amended, to increase the authorized number of shares of common stock from 69,500,000 to 139,000,000.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1.00pt solid #000000"> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="15"> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Times New Roman"><B>2.</B>&nbsp;&nbsp;&nbsp;To authorize an adjournment of the meeting, if necessary, to solicit additional proxies if
there are not sufficient votes in favor of the Proposal 1.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-RIGHT:1.00pt solid #000000">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="15"> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:8pt; font-family:Times New Roman"><B>3.</B>&nbsp;&nbsp;&nbsp;To transact any other business that may be properly brought before the meeting or any
continuation, adjournment or postponement thereof.</P> <P STYLE="font-size:24pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:8pt">&#9744;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:8pt">&#9744;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-RIGHT:1.00pt solid #000000"><FONT STYLE="font-size:8pt">&#9744;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">For address change/comments, mark here.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">(see reverse for instructions)</P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="top" ALIGN="right"></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="9" ROWSPAN="2" ALIGN="right" STYLE="BORDER-RIGHT:1.00pt solid #000000">


<IMG SRC="g400617pcimg6.jpg" ALT="LOGO">
&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="12"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary,
please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name, by authorized officer.</P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">&nbsp;</P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1.00pt solid #000000; BORDER-BOTTOM:1.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="23" STYLE="BORDER-RIGHT:1.00pt solid #000000; BORDER-BOTTOM:1.00pt solid #000000">


<IMG SRC="g400617img7.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g400617img11.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>I</B><B>mportant Notice Regarding the Availability
of Proxy Materials for the Special Meeting:</B> The Notice&nbsp;&amp; Proxy Statement is/are available at <U>www.proxyvote.com</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;
&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;
&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151; </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="27%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="18%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="23%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD></TR>


<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:2.00pt solid #000000; BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-RIGHT:2.00pt solid #000000; padding-right:2pt">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE="BORDER-LEFT:2.00pt solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000" BGCOLOR="#e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DYNAVAX TECHNOLOGIES CORPORATION</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR THE 2017 SPECIAL MEETING OF STOCKHOLDERS</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>July&nbsp;27, 2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:2.00pt solid #000000; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="5"> <P STYLE="margin-top:0pt;margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em">


<IMG SRC="g400617img10.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="9" STYLE="BORDER-RIGHT:2.00pt solid #000000; padding-right:2pt"> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS OF DYNAVAX TECHNOLOGIES CORPORATION</B></P>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; font-size:8pt; font-family:Times New Roman">The undersigned stockholder of DYNAVAX TECHNOLOGIES
CORPORATION, a Delaware corporation (the &#147;Company&#148;), hereby acknowledges receipt of the Notice of Special Meeting of Stockholders and Proxy Statement, each dated July&nbsp;10, 2017, and hereby appoints Eddie Gray and Michael Ostrach, or
either of them, proxies, with full power to each of substitution, on behalf and in the name of the undersigned, to represent the undersigned at the 2017 Special Meeting of Stockholders of the Company to be held on July&nbsp;27, 2017 at 9:00 a.m.,
Pacific Time, at the Company&#146;s offices at 2929 Seventh&nbsp;Street, Suite 100, Berkeley, California, and at any continuation, postponement or adjournment thereof, and to vote all shares of common stock&nbsp;of&nbsp;the Company which the
undersigned would be entitled to vote if then and there personally present, on the matters set on the reverse side.</P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; font-size:8pt; font-family:Times New Roman"><B>THE PROXY WILL BE VOTED AS DIRECTED OR, IF NO CONTRARY DIRECTION IS INDICATED, WILL BE VOTED IN FAVOR OF THE COMPANY&#146;S PROPOSALS AS
LISTED ON THE REVERSE SIDE, AND AS SAID PROXIES DEEM ADVISABLE ON SUCH MATTERS AS MAY PROPERLY COME BEFORE THE MEETING.</B></P> <P STYLE="font-size:24pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5"><B>Address change / comments:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:2.00pt solid #000000; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:14pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-size:14pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:2.00pt solid #000000; padding-right:2pt">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:14pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-size:14pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:2.00pt solid #000000; padding-right:2pt">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:14pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-size:14pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:2.00pt solid #000000; padding-right:2pt">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" ALIGN="center">(If you noted any Address Changes and/or Comments above, please mark corresponding box on the reverse side.)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:2.00pt solid #000000; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:2.00pt solid #000000; BORDER-BOTTOM:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:2.00pt solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" STYLE="BORDER-BOTTOM:2.00pt solid #000000"> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Continued and to be signed on reverse side</B></P> <P STYLE="font-size:10pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:2.00pt solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:2.00pt solid #000000; BORDER-BOTTOM:2.00pt solid #000000; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g400617img1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g400617img1.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!#P%O P$1  (1 0,1 ?_$ *,  0 #  (# 0$
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MG0O=^6A<(8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MQ<:OM0P+_ EJ9/MTU&\<PA@,!@,!@,#KSXB_NG\8/L\4M^KB-YT+W?EH7"&
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MRI,H+"WJ7)W>=MGC]4JHZ96MCL/YKU]+K0HQ;$(+$G*=N@['JJ2'1AN<H.C
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MHWY(,6CS2A&^-K16A[T+6AGE^N<YBK-.HE6CHZZ1SB=QN82^),1B-?LQZCD
M4QE'+W,A:!*)N)*9E,R; B :<68;YK6RPCT$>PCW3$9!Q00C,)-+"/\ ]@AE
MC $7LUOZ.Q:UH7LWK?L_XX1^#)-*T#9A1A>C ]Q>Q@$#0P^SZ0-BUK0@^W[N
ML 82<3V^*485WZ[@>( 0.\/_ .0>[6N[7_KK &$G$[#HXHPK8M=P=& $#8@_
M_D'0M:ZZ_P#7 X&2R1@AL<D$OE;PACT6BC(ZR62O[H=Y=L8X^QH3W-Y>'%1T
M%X"!L;TQAQP^F^TL&]_T8'*-R@AV3MZQL.+7)'9,B6-JE.+0B5J1Q)*4(5)
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M>2K/Z7_E0P& P*WL^T&:IV%'(7R/SZ2)5SJ4T%HJZA3O.GDH\U*I5A4JVIE
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MN@-Y@V\],+R"Y0/70\))Q469SZH9?7-&64S9%N1YMI)OE]=4%7]$6;;,Y/M
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M5G]+_P J& P&!^ZUO?W-;WTUO>^G]&M:Z[WO_AK6M==_\,#\^Z$(M=-A'KN
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MKR6X.N=V3GE-8+:AK$V76E3/&*OJ7ELG1FBE-?R.E;-FLZD[J!Y+8G%?$R'
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M=9J?GSNIS[-1IQ*1ITXUA:<I8).0)84D,&:D+5B*!M46D--+*-,2@/V+18A
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M9<]GT(+_ ..X+>=:0;+)@)%U*7H:-\@B/?E),KE">&(9;IN=CRV\E$ME6Z]
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M=T,:9=>CQ=F4R)_/TB;4VQEHTH0 V8:9H9HW1;JZ<(8# 8# 8# 8# 8# 8%
M7U_;^.7VI:W_ ,(V7DJS^E_Y4,!@,!@,"F[Y_P OVW_63C-_N:I_)5B/<1?W
M3^,'V>*6_5Q&\I>[\M"X0P.O#G-9B0YPIWCPVL4_-L*;7GQ-L6(KFF+/BV*R
M1BAO)Z%+[%94\H9RE*1 ]0F(L)[R\)W#RB<ME, =HPS6Q@#+Z-_7U0GEM>U]
MP&WK$9(/+Y+%7*/0*EGOBU5;+5[?,F#EA8LKF[^VVK$)9)%<3>W-$GC3>B;D
M(DS6YL)[&D7">E!II&M>'+:DD0R]U-U5YS.ORXJMDTL:&MG9OY:4/>(.@@;#
M)HE;4?G-\6A )RD>G]QC;C)$P8+#9:I6 ,85J : \9:E8(9.M%[7M9F9\IG<
M-E<H(]=U_P CBE@RLFNZ:OK@W7T+J))6,1=(K.8A>:NO6>ZW-\E*B)K)VZ%,
MR:6JE290UN:0MD5I!#/$83W$@<ZDS':0:'0## !WU" 8PZWUUOKH(MZUOKKV
M;ZZUFF73Y-"8JS?S.(V\IXZ_V5.Y5.:^95+4^PZUXK.Z/C3=3+J0*T:=M=B5
M#K"><57 (ADS&+O!:< )6H.-T:<K"G3;S_Z:_P#/LYKYFKS._F'Q:HVUSE8:
MN<+QE]4RVOY%'6T*=MA#'Q^=9RS66S$-%.%KV>(R"?(2 -,F<K 4;>!C4(@,
MY80:$2WE<GYU3E>\A.:2SE5&&M^G$\<:O=N1PH2X0A;4</0Q1/7[IR9Y85$6
M6&2(H"BE125GKRK(RY)UPW3NVH4:5'&&IU18-MNF3/=8/'7DY=,_Y%HXONWY
M/9"@WECR[JJS*54U"R,4*J3CS5;E9"*LK/;K%:H6UN*M[(E$>9&?:I4^+D[R
M-U.1A2A5(S3@);I9PU5QT=6MAY8<YJ^?_46643BXJ^MN+(EK"^)DLFK0KCG1
M\&63!CD VS4;=$:"5L:MN/*+5B5$*4X@C*UK77+.ZE_^8SSQ!O3EA9/)^>QJ
MWY+&6Z.-*B]DLLI%8V.R>35R3%[((8Z7=HP%/1$40M;0]Q$(3E2ESG4H#)2G
M M<W!)T2<25)N^Q9,X=LF:9,!@,!@,!@,!@,!@,!@,!@,!@,!@,"FGVTI"VO
MI;0SUJJD"159;?4Z!V]\F9F IEB^&%3C6S$"M I/3-1#49LL1VQB&(X/31?;
MO6\N?]#EF^5V<YS"309-3H/7(DS15]=MFV8PA0[0S$^2)V?RB@+$,PX_1D45
M^,$18/#UV;UL7=OMG&;IY1-%;TU<(%$K(3TXJ]W)J_12.,FAV+'0N6G*9RU#
M"F7SJ732(HA/ZTX%^,()@]ED]1Z"+>NW'&YHE8);9HYP?7NJ=#[PIHHDF9F]
MV8P^G^C+7=:R$Z"I]#\7:SSR SN!X?;H'3?=UWTTV9NJJ*3NTTLP-&/QL !%
M(XQ<H4P%CHMF36\JAN%>&VG W9"0U-S<4,0%;\C-\ [9N@[(#HP0==W;IG.;
MT2M6X0P& P& P*;OG_+]M_UDXS?[FJ?R58CW$7]T_C!]GBEOU<1O*7N_+0N$
M,#)'(&\+IJJV.,<7AT+ABJHK<N:(599LXDC^Y;DA"V:(9HH:8_ (BT;(+\^W
ME1+SJ]V=#A(P$GE)DZ8XT9IA$Y6341Y4W[=E'S2M4U>OM-2)-8$CA$5BW'-;
M&IZ]7[=:URF"!JLUTB;W'I2B8()%*TA3GIW.=E[*YMB?:8T+@H2@,)[EMBR2
MN Y3\A.0%'W[0$2BC_422GK?L%AB[Y(K JBV!-->L(5B!MD:N3WA'YR3 F"7
MV&ZN*5HA;.K9R_/N:H.E"C1)0QB7=))9[KG?N193?RICE I7".-D?;XDG'.7
MM\.6Z=E%K69IZ74E3$*\NH)0ZEC]"X!*I,[EGEFB+:$*3M"#:K0\;SB9QK3N
M5&.G?EN<U<U8SQ*#'FPR*/4!+7.L]'(C2W1LN)X89A8<2K@J+:)VG4H':JZ^
M='0U=LW1A2C:4K0-Z-[M3><:SC52,G\P5U<.0,ZX[.M>)65SCO+>(4+$'$Z1
MKC$D^JF0,3Q[Q6@U)?*A 5)8+/V734XM?41!9+@@4;,UYD.LFW3./X6PP<H+
M'>.63GQ//JS2-WC2IUL22SSU-Z%#R^+SC'D2:LIZS*QH@DK;*F%IFJ8LI81&
M>"AVP.*SQ!$:3!'=NXF<:IZEN8T$-DE84C"(C (S.K&Y=<B(/9]7QU]<=.4'
M9VR4\J'85W*VX2,.E;O:LFHA8J5 -V K2EP4BT+H K9DWPMGFOOIC^8?&[BN
MNMN/[<GBVIQ([2YAPFP(TW/STJ=:^9N-<@D3-#)*)*J;$Z%:HL=(S%'*2_%[
M4>U':7L?3+I?KDWX2#BAS#F7)2W;&@#BIH5H8:^F]RP\<,C<IL]VNUM(K"UG
M.LFB22-H>(BWUTE:Y%IOTM-"C=#SB K"0!"+?B]B72S(A_"GGC(>5-J.U=.L
M3JPI,G8K'D"E?4L[D<R>*J.@5PCJQKA5^-#U&FQNATUL5"$QY8B4B]1M2D0K
M.XD("@'"2Z68D/![F++N69DF<7G5 M+:RI'T8X57DHLM]M.**VV>O$0;@S]-
M*(BS0U.E<$K&<:+;:N5F!4# #0=E]P])=+,=@XQ"" P82C% P%F& 3D^'H]0
M,L AA3D;-&65HX\0= !W""'NWKKO6O;E989XF<G[2Y*Q:R75RAE/P^31MO2
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MJ:12%E95\YL6#QN6#31E @=@&*I,4!A>5RM4B0!TKT2G\70@  /K%BE;"I^
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MP6"")8X*@IRRM*5ZL0-;-.'W&F[UK8A;Z8'TX# 8# 8# 8# 8# 8# 8# 8#
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g400617img10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g400617img10.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ <P ( P$1  (1 0,1 ?_$ &P   (" P
M      4&" D$!PH! 0$!                   ! A   04  @$$ P # 0
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*OY%_K>?^">7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g400617img11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g400617img11.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!; &- P$1  (1 0,1 ?_$ (0  0$! 0$  P$!
M       (!PD$ P4& @H! 0$                    !$ $   ,""0H!"P0"
M P      !@<( @,!$P0%UA@X>)C14Y-7MUBXV F9$1*R<Q0T=!46MA?(,1E)
MB2(D(9$C$0$! 0$                 $4&!_]H # ,!  (1 Q$ /P#_ '\
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M[^)_7_\ LX_'_P#T%UT[$       0;"VU35_]SIE_0T>@W(
M                         'HR3[5D_P!-=_.P AS_  <_ZI/XAB[UU;$
M      0;"VU35_\ <Z9?T-'H-R
M    !Z,D^U9/]-=_.P AS_!S_JD_B&+O75L0      !!L+;5-7_W.F7]#1Z#
M<@                                      >C)/M63_ $UW\[ "'/\
M!S_JD_B&+O75L0      !!L+;5-7_P!SIE_0T>@W(
M                   'HR3[5D_TUW\[ "'/\'/^J3^(8N];#EM1=3$23?J&
M@&4\I) 9PA60\S(6ECAB"94\9EPC$D2YRS](63,[LKSG@AR$Z=Y@9JS7F_(K
M,WK&;KK!^*7][?8<AM7UJS=XS!=V2/L_W1KCZGZ0.)2>/E# _=&N/J?I XE)
MX^4,#]T:X^I^D#B4GCY0P/W1KCZGZ0.)2>/E# _=&N/J?I XE)X^4,#]T:X^
MI^D#B4GCY0P?H)1SUG?GJ>%N3$YI;RDA>]R^4F=)JP_G^54U8UF!=7USF6-,
MRP=E^9\\Y#&,G)6WF;[RW>9[N[ZYO;BWE>"U@N[=FW9L?\<-H/RD+;5-7_W.
MF7]#1Z#<@                                      >C)/M63_37?SL
M (<_P<_ZI/XAB[UHTF=H#U#-[.7W@(HJ$4J     #%8>VYX4W/X][<(#!YX6
MVJ:O_N=,OZ&CT&Y                                       ]&2?:L
MG^FN_G8 0Y_@Y_U2?Q#%WK1I,[0'J&;V<OO 114(I4     &*P]MSPIN?Q[V
MX0&#(,]SZD5*"KBJS-4W)V2BE5G//>9J;,Y9ES=,J9,'0+E^><W9+!T>9)E.
M<,U9)%&><UW^<<AR?*\.*MWMS9MW=B\_XX<."U_X!^PUUJ,.]_2UQ!2FTM U
MUJ,.]_2UQ!2FTM UUJ,.]_2UQ!2FTM UUJ,.]_2UQ!2FTM UUJ,.]_2UQ!2F
MTM UUJ,.]_2UQ!2FTM UUJ,.]_2UQ!2FTM UUJ,.]_2UQ!2FTM UUJ,.]_2U
MQ!2FTM UUJ,.]_2UQ!2FTM UUJ,.]_2UQ!2FTM UUJ,.]_2UQ!2FTM UUJ,.
M]_2UQ!2FTM UUJ,.]_2UQ!2FTM UUJ,.]_2UQ!2FTM UUJ,.]_2UQ!2FTM U
MUJ,.]_2UQ!2FTM UUJ,.]_2UQ!2FTM UUJ,.]_2UQ!2FTM UUJ,.]_2UQ!2F
MTM UUJ,.]_2UQ!2FTM UUJ,.]_2UQ!2FTM UUJ,.]_2UQ!2FTM UUJ,.]_2U
MQ!2FTM UUJ,.]_2UQ!2FTM UUJ,.]_2UQ!2FTM UUJ,.]_2UQ!2FTM UUJ,.
M]_2UQ!2FTM UUJ,.]_2UQ!2FTM UUJ,.]_2UQ!2FTM UUJ,.]_2UQ!2FTM U
MUJ,.]_2UQ!2FTM UUJ,.]_2UQ!2FTM UUJ,.]_2UQ!2FTM UUJ,.]_2UQ!2F
MTM UUJ,.]_2UQ!2FTM UUJ,.]_2UQ!2FTM UUJ,.]_2UQ!2FTM UUJ,.]_2U
MQ!2FTM!\^2UL47V<HN+5JL"EFS9P7MWAPX<-0<IL&#!@P6L'QPX<.&+?A@P8
M 9A]8N/[&/UO'7?U;^T]]8Q_R\&*Q&J!C,=\OX_)Q>+_ .7Q_I\!=:9)G: ]
M0S>SE]X"**A%*@     Q6'MN>%-S^/>W" P7/:NKNWA^-J[L6L/]/C:L6<.'
M_P!X<&'"#^<1<<S=='8Y ,1<<S=='8Y ,1<<S=='8Y ,1<<S=='8Y ,1<<S=
M='8Y ,1<<S=='8Y ,1<<S=='8Y ,1<<S=='8Y ,1<<S=='8Y ,1<<S=='8Y
M,1<<S=='8Y ,1<<S=='8Y ,1<<S=='8Y ,1<<S=='8Y ,1<<S=='8Y ,1<<S
M=='8Y ,1<<S=='8Y ,1<<S=='8Y ,1<<S=='8Y ,1<<S=='8Y ,1<<S=='8Y
M ,1<<S=='8Y ,1<<S=='8Y ,1<<S=='8Y ,1<<S=='8Y ,1<<S=='8Y ,1<<
MS=='8Y ,1<<S=='8Y ,1<<S=='8Y ,1<<S=='8Y ,1<<S=='8Y ,1<<S=='8
MY ,1<<S=='8Y ,1<<S=='8Y ,1<<S=='8Y ,1<<S=='8Y ,1<<S=='8Y ,1<
M<S=='8Y ,1<<S=='8Y ,1<<S=='8Y ?)\FS\GY/PP?)^'R?D_#!\GY/P^'P^
M']/A\ <ZY,[0'J&;V<OO 114"E0     8K#VW/"FY_'O;A 8+J
M                               !SJDSM >H9O9R^\!%%0*5     !BL
M/;<\*;G\>]N$!@NH                                         '.J
M3.T!ZAF]G+[P$45 I4     &*P]MSPIN?Q[VX0&"Z@
M                       <ZI,[0'J&;V<OO 114"E0     8K#VW/"FY_'
MO;A 8+J                                         !SJDSM >H9O9
MR^\!%%0*5     !BL/;<\*;G\>]N$!@NH
M              '.J3.T!ZAF]G+[P$45 I4     &*P]MSPIN?Q[VX0&"Z@
M                                        <ZI,[0'J&;V<OO 114"E
M0     8K#VW/"FY_'O;A 8+J
M     !SJDSM >H9O9R^\!%%0*5     !BL/;<\*;G\>]N$!@NH
M                               '.J3.T!ZAF]G+[P$45 I4     &*P
M]MSPIN?Q[VX0&"Z@                                         <ZI
M,[0'J&;V<OO 114"E0     8K#VW/"FY_'O;A 8+J
M                      !SJDSM >H9O9R^\!%%0*5     !BL/;<\*;G\>
M]N$!@NH                                         '.J3.T!ZAF]G
M+[P$45 I4     &*P]MSPIN?Q[VX0&"Z@
M              <ZI,[0'J&;V<OO 114"E0     8K#VW/"FY_'O;A 8+J
M                                       !SJDSM >H9O9R^\!%%0*5
M     !BL/;<\*;G\>]N$!@NH
M     '.J3.T!ZAF]G+[P$45 I4     &*P]MSPIN?Q[VX0&"Z@
M                               <ZI,[0'J&;V<OO 114"E0     8K#
MVW/"FY_'O;A 8+J                                         !SJD
MSM >H9O9R^\!%%0*5     !BL/;<\*;G\>]N$!@NH
M                      '.J3.T!ZAF]G+[P$45 I4     &*P]MSPIN?Q[
MVX0&"Z@                                         <ZI,[0'J&;V<
MOO 114"E0     8K#VW/"FY_'O;A 8+J
M             !SJDSM >H9O9R^\!%%0*5     !BL/;<\*;G\>]N$!@NH
M                                       '.J3.T!ZAF]G+[P$45 I4
M     &*P]MSPIN?Q[VX0&"Z@
M     <ZI,[0'J&;V<OO 114"E0     8K#VW/"FY_'O;A 8+J
M                              !SJDSM >H9O9R^\!%%0*5     !BL/
M;<\*;G\>]N$!@NH                                         '.J3
M.T!ZAF]G+[P$45 I4     &*P]MSPIN?Q[VX0&"Z@
M                      <ZI,[0'J&;V<OO 114"E0     8K#VW/"FY_'O
M;A 8+J                                         !SJDSM >H9O9R
M^\!%%0*5     !BL/;<\*;G\>]N$!@NH
M             '.J3.T!ZAF]G+[P$45 I4     &*P]MSPIN?Q[VX0&"Z@
M                                       <ZI,[0'J&;V<OO 114"E0
M     8K#VW/"FY_'O;A 8+J
M    !SJDSM >H9O9R^\!%%0*5     !BL/;<\*;G\>]N$!@NH
M                              '.J3.T!ZAF]G+[P$45 I4     &*P]
MMSPIN?Q[VX0&"Z@                                         <ZI,
M[0'J&;V<OO 114"E0     8K#VW/"FY_'O;A 8+J
M                     !SJDSM >H9O9R^\!%%0*5     !BL/;<\*;G\>]
MN$!@NH                                         '.J3.T!ZAF]G+
M[P$45 I4     &*P]MSPIN?Q[VX0&"Z@
M             <ZI,[0'J&;V<OO 114"E0     8K#VW/"FY_'O;A 8+J
M                                      !SJDSM >H9O9R^\!%%0*5
M    !BL/;<\*;G\>]N$!@NH
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M#@LVO@'3
A                                        '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g400617img2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g400617img2.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ .P%) P$1  (1 0,1 ?_$ ),  0 " @,! 0
M       '"@4& @,(! $! 0$! 0$                ! @,$$  ! 08!"0()
M!@L)         0(#! 4'" 81$M8GEQA8:*D3MR&Q<C,4%39V.#&1,A87>$%1
M(K0U=2:V-W<9<8$C)-255F:G$0$! 0$! 0$              1$A,4%A_]H
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M<OF<U47/=I^#*A1O9     &GU$F$;*:>X^FLMB7D%,I7@C%LRET8YS>VA(^
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M+APXAV,N9#N',.QG+E:5APZ9=,*TJ(B*TK+"9? GA [0   !^HN147\2HOS
M83#\A@<-RYJ5RYJ(:AFYI/INJQ3QEZ]]+Q'/9EB*8(C;#MVSV+,PFKU'3.3*
MRZ1E%55154&()# XEEBRF8M1#,*LQD<S585XRZ?>DX>GLMQ# )GMNWK/9-1\
MJ=(\3)E:=JTB*BJBH&;5<JJOXU5?G PDLD,#*9AB29PK40L3BF:P<XF:/GC+
M;IB+@I#*,..681EEVPKIRLODKE6F6E;57JM-94141 S0         !V.O.,>
M4@%' P]"X5:9\*ELGW>J+]W&&S4\<+Z] E0
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5_NSO!\X.*@O[1?\ =_\ RTP[O__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g400617img3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g400617img3.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!(0 Z P$1  (1 0,1 ?_$ *,  0$! 0 " P$!
M       ) 0<%!@(#! @* 0$! 0                   @$0   $ P,( P<,
M#@L        ! @0#!@<1!0@Q<;$2=[<XV1/6ER$4E%875QA1,E-4U!75%C:6
M-UA!T9+2,V.3TS15E4?7.2)BLB-SLW0U928H$0$  @,  00#
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MY=%IG<]=T!@     TLI9RT@(=\\L1:Z5/PN<,>&_8'1W=W+HM,[GKN@,
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M)6IJ:O<MM[AKV4!I92SEI 0[YY8BUTJ?A<X8\-^P.CN[N71:9W/7= 8
M-+*6<M("'?/+$6NE3\+G#'AOV!T=W=RZ+3.YZ[H#     !I92SEI 0[YY8BU
MTJ?A<X8\-^P.CN[N71:9W/7= 8     -+*6<M("'?/+$6NE3\+G#'AOV!T=W
M=RZ+3.YZ[H#     !I92SEI 0[YY8BUTJ?A<X8\-^P.CN[N71:9W/7= 8
M  -+*6<M("'?/+$6NE3\+G#'AOV!T=W=RZ+3.YZ[H#     !I92SEI 0[YY8
MBUTJ?A<X8\-^P.CN[N71:9W/7= 8     -+*6<M("'?/+$6NE3\+G#'AOV!T
M=W=RZ+3.YZ[H#     !I92SEI 0[YY8BUTJ?A<X8\-^P.CN[N71:9W/7= 8
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#Y?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g400617img4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g400617img4.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ QP,. P$1  (1 0,1 ?_$ *L  0 " @,! 0$
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M' <!P' <!P' <!P($G?^Z7+/[OV]?]1NNG"]ORGOA#@. X#@. X#@. X#@.
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M_@!.41^\7._@9,0 X#_K3X"41#S_ /7C9]5Y?/VOT;U"7[E9;U%,)#%'1<[
M0,!?6)1 93\OH^/_ -../J<@W#1@,)1Q66 P>KR4=%SH!#T_SO(#*_#QQQ]6
M;YR=;'U]K=('R 8I+B)1$! -&SH1 0 !$/ 2OGSX'C9]5GEO1^_:S2?/C[DY
M?R/D #[Q<Z 1$/RAX&5_*'\O_AQQ]5Y8BP:1=ZO!2]DFL8G4(B"C7DQ)K(7W
M/7:Z4='H'=/%D&J<J"CE1)NF8P)E^D80\!\1XXZ:<IB__:'P$!_\!^(<!P'
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MQE5E!$YA$PB/,*[9DDCCY.BBH;QX]2B29S> _('J.41\!P/GV&__ /;-O_\
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M]5XG1*FKE0X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
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MZ'I]7ODCA6!X9'T_'U 02^/CYX',"Z!E3MRKH&<))D55;%62,X224$2IJJ(
M<5DTE#!X*82@41_(/ _45D'"95FZZ+E$_GT+-UDUT3^DPE-Z%4C'3/Z3 (#X
M$? @(?EX')P' <!P' <!P' <!P' <!P' <"!)W_NERS^[]O7_4;KIPO;\I[X
M0X#@. X#@. X#@. X#@. X#@. X#@.!QF60*LFW,N@5PL155%L99(KA9) 2
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MF95MU8UVB,D)CE0$Q2E./@0Y>GE\X;L^-7YP]]U.HMMW4<2G8ROP%>84Z8U
M8.833P*LN3LGA63V E"KGI\585691&7!LX#P )BH4/ >,7VN:LSLLI>+<_JE
M27M%?I5GT]P0T:9E6*(,.M.RK6262(#^./-2<5%*LVK=4%SF,X+ZD0\D]0^
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MFH7*IYE0G_91A8328?9(+GG"\?\ *Q579M#G(M]7-/6?T$!0WJ,'E)-O3?\
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MJU+*J'22]U9?++TG\[9I+KW;%H8\Z#"T2*LE-GFY#.K'9R(K*L5I 45WC8J
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M=1;*=L4XWM5&]?@J::U.66BJ?*Z=\^N!(K7K#5I2YU^A&9 B+,1?P$<'TS*
MH#A0"^/A\;Z_SO=-YQJ&L]N+U4-GN.242C9I+/J' U:=7A]$TP<_NNJ!96OS
MQXW'&#QA]1S#F-1_H3'=NBE4=@*8%#EGC+-NEO:,YN_:6UYIH=%S.K5?.HF>
MM^>NM!&3W:^K9S7E5D'A6(9U!2;!E(,G]\!?U L51PFV1 2CY, ^>3Q\=FEO
M.18J+O<VZQT-+FJ<[J=A3SV3N4A1Y:19OEHJ3C(1[*'AEY>(4<,GK199F'MN
MD!$%&ZA3@ &$2A+USMJ]M4VR#NK>;[/82SGZ5CSJ,W58&S6.RO67EPT;/_7
MNIP96_4EW!-3Q$)'IM13?*BN7Y8Q@^(CX*;5\9-RWA)7HMS"G <!P' <!P'
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M518RZ=IVM1IE<RQ_ 0/7&A42YDC'5DKB[R86LHVF*<N602#E #M/0H8%#@J
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MD_K:J4_YMTG%JM/F3E:"LHL1KZ_Z("B "%OE;Q4DBWO,J<!P' <!P' <!P'
M<!P' <!P' @2=_[I<L_N_;U_U&ZZ<+V_*>^$. X#@. X#@. X#@. X#@. X#
M@. X#@1M(9]3WFOU'5'CUP2^5RC6FF0,9]:M$F3RLSTI%R4ZZ4A#)?//EVKQ
MD@4'":@)HE/Z3 (F >7;F=C.=0M5.KN<5'9)S1X'5M;)>9ZUFT6VU'[TV@PM
MB?*>\5J-GIC2-;N9&O,6SD$6J2XBFB@0A"F\!\;?*V9V3.64K76C(H+6$[LR
ML=LEY>LV6Q:' YI+7LDU4:#;[RW^4L%PA:BH49:-=RS=0Q4?F5U&K?W!]@A/
M(>'M<,C;ZWBL.X@)N#UEI#ZZC(:9=+U!,KZT)>VE7C[$_$8B BU+0R4,FC%1
MI1(4J:*2: +'12 4R@<\M^G"Y]6B1G5K%:UDL;GM5F)NEPE>O*VAPN@5:V1<
M!;8B[_6+T4I8UI9,D8I^=@F^/&IMWK==(&9$VQBC[9/%]KNID=E/K7CB63M:
M;'V.PLF$%>U]<0UIE>6HWQAJ7SBKQ_HSB\G35C0G5E'!TG *H_*?+F]D4@+X
M\/:[IDS&0AL$BJK3,MJ64VR=AH&LZJSU.R6$;4^?R^BIO'$I+V@+#(1J96EL
M&[R+X@+D4,@R(GX4*4WLII&;MV_1<^C>X*HY[7M0T#1F-A;*WC26E.@)]F\L
ML0N1JWHS9XPA(N%B2BF]8',=^J==(QE3*N#>0 H_#DYS.PBYMUAQMMK);:C8
M;(,DUOSK;4,C-=F9Z4RTU^Q%@YTI*E?+_72<@JD<5 ]2XL2KC[@)>>7VN)DU
MG6F 9N77S7US<+K.SL=8W>EQ.93>@&EZ94[C+Q1H%S>H6E./7)1KA6-6.FW
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MJ8LQ[J8Q:,H=UB5-9;KN5(N4;5%IIOK2&IN(55[<IW6S6/WYB9S*)!H1"/:
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M/JQ=7EKM$Z]MKW:F,? R\@D:M4N'@\J;$+%U*'0123;'D7ZZ[M\Z5%5RX45
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M+[M/7*$IR\?9IG#[:2(E/K2O)%^H)](9*/0EZFZ?(*>XV \8Y;IOF8D_],Q
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MK"LF3.-9M8^.9M(^/8MT6C%@P;(,V+)HW("3=JS:-B)-VK9!(H%(FF4I"%
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M6%Q37$6P34>34)4:_GK.V7&!!43HNVL)*L'BZJIRB0%$C"8I@\@+VFRTR_\
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MYD78>L:79(VOAF6AX7,,Y3-M6(A"H(1[3L'4K,N%>AW]?> +1X59L8JC$GJ
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M?:I^,SGM',WEK326%TOV):]<WZ$O 0C)67;2J,PYNT,PDS*"B1Z$F1BJ)"J
MH4/3=FWIT.?^5BL&MF@9/B^:Q^Q0>A24K=MIDJ#3&D^Z9RUXJ5&MMAE!S4VD
M.WLE\TLXBXAL5-UX4=/42*)E.4?0<2YLE\N/HO2-ZC:Q:K1VSM%WM<+*(4C)
M\OKM3R!Z^2,$1(6>_K.I33;)"F,8R:TDRC6#*(.J  9)$3$ ?!S<<>N=]7NI
MPSRK64^UB-E-FMT3F2=K9'0%Y@S%@;KB3$UJ9]1(W=FC\S\J3;54B F9Z"82
MXNQ'U?T?-;/7\?EGG?R[HXE?W?9>#A:Q7-CK.<UGM0\[ RR%D8U!;(037@'"
MDO<:?>6/ILTE)W*67(U;5]8!-&^MPHJ(AX]$V>O;<,Y_*;NP4A/[/0W;FAT6
MV2<MUV[5T"2GZJ",:>8ND;FTE&3,^[IK9&141DRJPUB3<LVZIT7*AT3$$A5/
M!1DXO/>+>C*X%EJ\[3MQGM/SM5HSUOL'>MGJ%"O\0S5F(9D",>VI<I.0*JCU
MM&V%5U%_.IH*"=1N<Q#&^GX\/*],^A)]6ATEWMF&=#,QC*GCUBM>WQD*6!CJ
M2X@BR3RIS$A8["[^U4_%**D];:O,3@Y(D"A!77413$Q2G,8+Q?/GH<SQ^4@=
M<UW.98Q&)I8_O*ECGM4.E>AN\-7V^A66U7AVT=VK9)U@RG'$:QI2#E?P<$EC
M*-6S8"%3.)?4:>7-ZPC):/E1R]H^MNA5*BH@U0F]BE-4N4/%-R&%W(9G'UFK
MO+7*E KE<5RLR,V?N"8I0)Z2@7R/E+Q8=XB'3)71;YV>K%?M>"[(^P?+[M7)
MJK/*?6(?[.WW3TE$V[?3=!FWTLP=#1Z!\X8[!LW264<'2.NJ/I B?+,GCQ9I
MW^&:UA#4;WV.R(8K';_&2V2[ R<,+U(OF$_@\YC,E$NRV^ZJIK@@WA]/,5U\
MBP3(B:7:'+X(L*1A#B9)?F%W49VO!^RS3M9F&N+L,WNI9#;+',&MK-.YJNJ-
MF36GR$#7*G:"G008PT#&0+M?Y(K'W!=6)V=5R8R9_)4OCZV?"9=UEW%"T:)[
M(_6.947?J79YWL>K<-+N4K=AF>O=SQ1S$)MYAX+)N>/A F)1HU;M6<8=BK+,
M%T0*+DY"D$K9G.9GY._Y>F@^/(^/R>?AY_T?R<PT_. X#@. X#@.!4?L/_QV
MZ#_WA]4_P>=C.2]8U.E2=@7^PL__ ,\.S7^(_5>)T2IJY4.!P.C.2M79F2:"
MSXK5R9BBY5.@V6>E04,S1<KID540;*N0*50Y2F,0@B( (AXX%-<WV_LC<-NL
MV/3^3XU#?=T- ?:+,Q.FVR2.T@;\W<O6;FIMW5,9DFY1HS:*"=!P+1/W/27U
MB B(:L\<WE-NM'==\X%KAMJT=1MGQ=(K^IRN?-,F4OB!)N2BX[2FU'3L'R A
M]H2F7B53R D(U,D )B &%/R8+Z<YV-X^6=T;M9>:WMVE9)6XKK[%L\[C:6_&
M>VG9G>9N)X;?"C+"G#M/J*2;O0BCIF(N)#_0*9,1_G\D\9F\F\XL=>]9997B
M4OL5Z:M5TZW3&-CF(NGO_KAE(RSY%DBUB*M+.46H23.4F'Z2#-THFF"B2A53
M% /(<F;<B[DUH^;Z/V'?6J)C-APZN5"IV6LR%D8W&B7E>W-*2X8-T'H5G26\
MG%Q"C64>LUA!%Q'@X;F73.00\ )BVR=DV]T(CV_UA3/GO8QGB$ OU@8R;DYI
M<][<I[ ZHK*>-77>DM:A]3C7OJHCI,RY6!G@.S-2B;U?R\OK-]=_HV]>S;9'
MN A#=J1P64K,:C0E:,TM;/32RSH'2K]_G\CHK",6B5&I6:2#Z$A'@I'][UB*
M0?#\H<GK_.F\XAVI=_+C:\$O&P$R:MQDW7->S3,X2LR%KE48R18Z8G$+Q4_,
M2OU49S&F0:S2*IB$24)[8^1'^3EOC)Y2?";QJ=Z1V?E0GMVJ6R5BFU.:P>@Q
MVG3LUG5Z&_4N1JLBTE'!6X2KB+B'<784%8LQ1:K)B)RJ%,'@/YTOCTLZ5=^K
MYPGM+*ZWC.H7^PT)*C7S+&DQ(3F?+R3IR4L>>CHW^E/U'J[5!TFUM,$Y((F!
M,?;,4_I\^/'%\<N=B7CY:1EG>1EJ50Z_SD=4&<?8M1V9ECNBU=S*O/F<]>O:
MO+VME,Q@G:)K3#&9BF2"[$RY$2+(K'^EZDQ\V^.6DNN_8>X%DK,O;LF?9M'.
M.R#33Z_1LWSEK-R(0&B5.W$/)0.I(3:L>+UA4XZOL7JTN;VSBQ<MP1$1]?D)
MZSK_ *F_M)G:GL-(=9\ZJ]["H)7=24OE;J,S$,7CQJLDQDH^5?S$C @1JY7>
MO6B<2?Y5!8I2J 8/68OQX\9/*X6XS>>;_$:3K5OI, G%.J+"9%F&M0%\;R"J
MAIR,T8\R8Q'3(R0-F+:*:Q0'$P*&.!Q.0Y2B3DS)O==YQ'W6;MB7L'+Z7%NZ
M=]COLTU1MV>J*/EW1M!RN0EK#!15V*1=N@#45Y6O'3532]Q,GO$\&_TV^.8D
MNJZPO^8]+2G7VZZJME<.A?J]H%4J$!GZ5DD3L+%$6V*?SC*Q_69XXKY%)&+K
M\J<Y2)&*!F8 )@\CXUZ<YV3VX299NXUS:3>.P,!6L6B%M/P"!VY[+:YJK[/:
M]%KR[Q%FK5HN5&$?DDG28N .B!RIJJID4,(!Z>2>,R[O5=6FA= GU,4?:;.-
M:,\G(^FVRUF:9_;%K=19$(!I+OF"4+;18LEI%F^0CR%65*@'M*F4*7U>@!'.
M<XJK:_>IE 2O4T+K3V,)5^R&<,;G8[*VEGKA#-I*9>Q\3#HKE59%2=ULTS)H
M(.'BYD3H@J4_@? @.O3K\)O3Y;<[[;2+:DVZ8;YZA,7A+LW8NL>:4QC/&:-K
MA9HY^DUBY>;FWC0Q8&/%H"SI\)$U@131]*?J$WD)Z\Y\::F;*;AM4Q-6FL;/
ME4+2WT&UB9*$N-%LSBTYY;6LF*Z;B,8NI9E%3S"Q0:J(?,HK-Q2.F<#D.'Y!
MESLLWNF\I3'$"E*8QA_(!0$1'_Z 'D>01CM&I0V(YC<-.L+%]),:HP153AH[
MVR24W+2#YK$0D&S.O_1(N)67?HH^X?R5(IA.(#Z? V3;A;DU'>>Z%V)7M!83
M8L/KE6A96HR5HB;=GUW<6^'KTC'$26&DWTDI&0[IG.NT5?Z!PQ*X:JG3.7X!
M](+GCVJ<]VT]=M6>;CBU!U=_"-*X\N<?(/5X1B\7D&C S&=E(<J:+QRB@NN"
MI(X%!$Q"B!CB'Y \\GE,N++LU$E>[8(3O::>Z_C4R-JDS5G:K7],^L%CI3^J
M5"NP=JMU&(R% &A#1,-,&$#E5,H95$2B7X_"^O\ .]TWG&D6?N!?&VSZ%F=)
MS:A6!#,;37:S*U.?TY"I[7?4)EO'.GEERZG2C%"$FX:/1D/4D"KSW'0)&$OI
M\@ 7UF;]3><9?;^UMQS_ &)[C]%I^:OI>'H,7?3#K.DFS5UH'ULX>I)5#+"J
MQSF.E[(V*R$BPN7!$BN#@GX^ F&3QV:6\XL'HFGR5%P:W;&I4G3>7K&:/+ZK
M1YYTFW>-9!I#%DUJU+/8T7B1'#5<10550]P@F+ZB>0$.23;BWIJ/\!V'3-67
M3>VB+P5G7G53C[$D3,=>>7ZWQKN7*Q<1S&R5Y6!CDX5'Y9=8BQSK"9-TD"0%
M-](0MDGU275H.94X#@. X#@. X#@. X#@. X#@.! D[_ -TN6?W?MZ_ZC==.
M%[?E/?"' <!P' <!P' <!P' <!P' <!P' <!P*OQ78Y:=[-HX$PH<]'P250O
M4TZO]D:/(5*;GJ1+0\6_94J/6)YFZVT6E/;6DS>A)9</2W Y2&..L_G4WG&#
M>]AM,KVUT:A7+'8^MT/4-(L^:4&:4N1'VAR1JU!'G!T-]3V3!>,;9_(D2,0I
MRO1>-@$IEB%$0(+UF;.IO+MQ?8+0"]C(K$K3F$)#Q5I:WB4K3V'O"-CO416J
M<5/ZNO>@UB/8GBZS4+XMZD8HP/#N 7+[:I?6!B@R9J[SB>+O<*EDE&L%TG2I
M1=<KS=>07:13)(KF2DY)[Z6D5$1S8B?S]BM$\^(@@D4HJ.GCD//D3&'DDVX*
MD..YSYOU0K78MS18&'L=LO:-!C*/8KC]2P;&57O,I5!4G;>ZCR$C$(Z/B%WC
MM4R()HBF8!'T!ZN:]?Z]>R;QK,SW:Z;J.(431[1 Y2SMVG7P:3448O764WD#
M=J9.0?C<+%J+".52:P,7#1#A=ZF@W4<$6*5 H>LWPGKSDW#>%@,=N3S5LYI]
M]LM<K$7+/C/GK9*NV6$T&O)J-W#Z)1GZE:XWW45F4O'B<R8^$7B":QT%RE,!
MP&7BXJ%Y[;MYK^ZT7)7.19N^A]!L$\I#R\5I\L\M$?F5962--:)8JX:IH,H=
M!JT<(IE0,[."T@L1LF8X^HQ;DS4V[C6F7;NQ.^Q88O\ =Q$$AU-9D\F*F%I=
MFUAL$=5RV8-8?T/ZG!BWR1XF8$TY#YL?)1 WJ$?H<>O&F\XYH7MY*2>HLH)S
M08ECE$UO=EZTP=P^U:A[Q]YM:BE) \A+4PT6FS:U"6=(&;('3=G=)B)%%">@
MWCE]>/G--Y^$V[GJ*>&T-M.0%583UCM=]J]$J-:^93K\9+WG1)SY)L[FY)JS
M<J-615CK.WS@J*KA4"#X\G-Y#,FU;<:'5NS+EYF%_MEHSJ=5O^8:9.X]9\[S
M8KJZJRU\BG#=*/\ LP_5:QJOV;FD'J*XO7R:!&*'N'7'P3R-]>?BIKFIFYZ7
MHO6W.MAHF2L[1H&BC&HMZ*VLOU=7*^#^QR,*[G9NQ/4#/S5V!:,/F'7R[=5V
MH)O2DF(?$&2>66\&\;&W]>-C?[92IV>EZ['UR<J>A7+-IU&!F5+%59.7I;Y)
MD\F:E/+,V"\G /3+ "9E$BJ$4(<@^?3YY+,JRZU:?['K1_9'/<"C*%/*Q]G<
M6UE8-#FVCR(@4I6NTM.XI0M).H3TVMRBU<H?6+@/2U:^^5,ICK <I+G&IO.,
M'HW8?3<WTRO1,SCD>AD]DUBFX[!6IU<B%OUNFK@R.X&V5"F,V#MF[J-><D,D
M\*Y=(/?20R@$*7QQ)+.O)O/P[UD[ 7^J=@Z1DDOF,&6I:':']9JLJSO",CH[
M^.BZ^>8DM17HS%BNTC<P8/TS,%EW+I)VFL7U&('DI!9,W3;KNW7LU%5OL7E?
M7B%@36&3NCUZUNMC!VJA'4)4]8E+-7H<?:;+(R-GF6$4=R=H91(6[$R:IA$5
M2!Q)_/L;SC2XKM39K-V8L>%5>KY<YK]0N:%2G9F:UV/A-%<E;5^.F;'*5G-%
MV1GUB0A7#\6_] KX.9$_Q 2& %\<\=-YSLNMS*G <!P' <!P' J/V'_X[=!_
M[P^J?X/.QG)>L:G2I.P+_86?_P">'9K_ !'ZKQ.B5-7*AP' @RC95+U7L'MN
MPO)2,=0FH0N4Q<3$-2NPEHQ7/XN182*LD=5$K(R;]1Z4R'M'.(%*/K\#XY=X
MD.ZKKKHXJYZ\V[,C#F)M/L&NR^@Q^CJ5PQG+&#D-3:7A"'4FQAS68KI*"1.R
M,5,PH>L_I ?:$1YKV_K>R9QG=M-YZYZF[WC5=9J<5UHN$-I470F"41N%3LMD
MD:\>F0:D6NI&#&L56;8LLLN8ROI.83D33\^!#QR>TS+IEWLL+H&3AL&%3.0W
MY>,AG=JIK&$F'U';+I0T#/,2LG;*0J;*3]+@L5#S+!%1L@N)3&03!,PAY\A)
M<NQ<XQHV>9YV2&XP,MM&OTR8I]3JTM6D:;F-;FJ\UT5[*M6\>-GTA6?=O@3=
ML6B G;M(_P!*)'*AC <"B)36V=DF]T$#U2WQ'+'O5IEI^;)];WKQW'%L2U>L
M9MI8YJ_GSV!U0$42KA3EG7E4[4DH8P'!N;_T_/@H7VF^W/L9<SLZ_8+H_:-:
MF=6F:C<JY47%H8X8PSYRY+-&?5AOF-=M%.L[>379LU!,C/UBT*H(>P)Q,)?"
MH% >)YYA9KOSW2:6?T#7\[C9RH)0.@[EC>B0K%\VECLV=&S.%J4'*5F:129G
M!64F65>5*G[7K;B58 .8/I>'MS+WAB6]=ZK56PY',XUBU?HF.5B_W"K+Z:I
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M1*FKE0X'7=HG<M';9-RNR4<M7+9-ZU$A73-1P@HB1XU,J11('34QP43$Q3%
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M]*!^'P'\H<PIP' <!P' <!P*C]A_^.W0?^\/JG^#SL9R7K&ITJ3L"_V%G_\
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MX1FT5L]PWJ/B%VU_OM5)4+<)7135Z:CBJL5%'CJ#.@9$TNZ3C4$EU_7X623
M#%$1$PMN9V,YU'E4Z<8?3;77+1%,+DZ;4F8>6*@4:=OEBG,US^?>BL967IU)
MD'*L;$.T#.#BV\BH1J)O*12B "%]K9B9$\UBHLZHXM;EI+V:4/;K4_MKPEBG
MG<VC$O)!!JW4BJTDY "P5;;E: 9%BE_1)'.<P?$P\RK9$&K1H=11HT:-%%C
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M]^+3]3?9S^'O0/S+CVAE^/V??BT_4WV<_A[T#\RX]H9?C]GWXM/U-]G/X>]
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M]^+3]3?9S^'O0/S+CVAE^/V??BT_4WV<_A[T#\RX]H9?C]GWXM/U-]G/X>]
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M]^+3]3?9S^'O0/S+CVAE^/V??BT_4WV<_A[T#\RX]H9?C]GWXM/U-]G/X>]
M_,N/:&7X_9]^+3]3?9S^'O0/S+CVAE^/V??BT_4WV<_A[T#\RX]H9?C]HZBK
MPG<^TN>"E2M1J1([K]N0"IH^=6&AI2!G&C=>/*<.I.H(EE%&H)@*Y4O(H@H0
M3> .'&R]%Z1;+E9. X#@. X#@. X#@. X#@. X  $?R (_\ TX#P(_D 1X#@
M. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.!5'?F+MWN/199J
MW472B][U*1D5$P 2LV)NI>_1972PB(>E$9&4;H^0\CZUBA_+Y"7K%G2O37F
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
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MQY@?3J'1G;(,QN]EFJG'J2#I^: (5RBH#8"/O7[IO +"8;9.?PDVO4X@>"$
M0\"!" (>H3^! H (>LWTC^!_\P_$WY1^/,-/K@. X'T7SZB^"^L?4'@H@(^H
M?/\ -\!X$?/Y/AP*<9+=H6Q]B[[!5#:PN%>J='=0=BI\M;B6.<G-&0N:KV8M
M\=#D\-:U7Z7&/D8(3M$VS9ZL<"%2,#;WCZL_GHDNU<7F5. X#@. X#@. X#@
M. X#@. X#@. X#@. X#@.!7W6?\ B]U6_P"8FE_]#[WR57H3S <!P' <!P'
M<!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P'
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MKC3/L?B0H_\ 4WL%_#)O_P#9UQIGV/Q(4?\ J;V"_ADW_P#LZXTS['XD*/\
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)"MT%E2-7'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g400617img5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g400617img5.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 30"N P$1  (1 0,1 ?_$ (X  0$! 0$  P$
M       '!0@) 0,&"@$! 0$                   $"$    P8 !PH-!0$
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M'< 20-?'I=&G:UR"4+Y^I&ENOA(P3E?Q4 $$B]JVG/QBKK3$FX+HO8(
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MAGYG4VD;AXY>NBN'A&;XK6F*;<85@_)"H>LM<KE DNI@ ^2%0]9:Y7*!)=3
M!\D*AZRURN4"2ZF #Y(5#UEKE<H$EU, 'R0J'K+7*Y0)+J8 /DA4/66N5R@2
M74P QZBMQB*LI^?4I4=Q%R4TIZIY+-*=GTL>5,EKAW,I+.X%_+9K+WC^$1Z'
MBW+N,@8EX[,=T\=O2L-NE,4VXU@JZ/<NG<.Y<P[IF]=0[ES#NBM:UK6.G#LK
MIVQK6^%K6$(SP_J"/L           !S:HVTO;'Q3N.X D@:^/2Z)T@3Q?7*3
M4ZZH>$0Z8T@2=*0RGXVL9@H\FJB(@&JI6YFFG<KD,LGTG@XPD2UX3<AXQ^0Q
M"E/NE:9I"YBM%FE5APBZ;%%M.4:NYK"]MDL81=-BBVG*-7<U@[;%C"+IL46T
MY1J[FL';8L81=-BBVG*-7<U@[;%C"+IL46TY1J[FL';8L81=-BBVG*-7<U@[
M;%C"+IL46TY1J[FL';8L81=-BBVG*-7<U@[;%C"+IL46TY1J[FL';8L81=-B
MBVG*-7<U@[;%C"+IL46TY1J[FL';8L81=-BBVG*-7<U@[;%C"+IL46TY1J[F
ML';8L81=-BBVG*-7<U@[;%C"+IL46TY1J[FL';8L81=-BBVG*-7<U@[;%C"+
MIL46TY1J[FL';8L81=-BBVG*-7<U@[;%C"+IL46TY1J[FL';8L81=-BBVG*-
M7<U@[;%D.K-XO1E[0EY.H1$'-3NJ075E%04HF"C1-.QSUY\IV5&>KIG'2R$F
=DJ=0<J*5L 6!A(PT3%':Q\9P[)NO%_\ /1:C_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g400617img7.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g400617img7.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ -P,9 P$1  (1 0,1 ?_$ )P  0 " @,! 0$
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M?^4[=_#PF!/<!@,!@,"!1O\ F=<_^AM;_P#/=I8]B>X# 8# 8# 8# 8# 8#
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M=IL"B[AN$]*1G+3<.8^PIN=?36IXF&:-ZG1[54'<'".2W]T=Y(KG62(HB@F
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ME:[+VJL-;2NUY<Y2XU&+L;&N7\5+@D(U9S*,GZ*]A!9:, CA0Q"S'["W*94
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EUJ[A9 "IH(@/6,/I'H#T!BN$F=&G'9@_^LC_ />1_:YKHX?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g400617img8.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g400617img8.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 4  ' P$1  (1 0,1 ?_$ '4   (# 0
M      8' P@)"@$  P$                   $" Q   00#  $#!0
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4Q'1;:<N#.+4TWA3G7-4ZAZ1__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g400617img9.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g400617img9.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ <P ( P$1  (1 0,1 ?_$ &T   (" P$
M      8(!0D!! <* 0$! 0                   0(0  $$ @$#! (#
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%]">7_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g400617pcimg6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g400617pcimg6.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0(" 0$" 0$! @(" @(" @(" 0(" @(" @(" @+_
MVP!# 0$! 0$! 0$! 0$" 0$! @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @+_P  1" !@ 4H# 2(  A$! Q$!_\0
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MNW<Y>21V=CRQ)KV+_AF/]FK_ *-W^!?_ (:3P#_\H*9^S-_R03X8_P#8$O\
M_P!2/6Z]SK513^7_  &!X?\ \,Q_LU?]&[_ O_PTG@'_ .4%'_#,?[-7_1N_
MP+_\-)X!_P#E!7N%%/D7]?+_ "_$#P__ (9C_9J_Z-W^!?\ X:3P#_\ *"C_
M (9C_9J_Z-W^!?\ X:3P#_\ *"O<*Y/Q[?:QIG@7QGJ?A^]LM.US2_"OB#5-
M(O\ 4;/^T+"VU#3M+N;VUDO++SH_M5OYMNH9!(A8,?F%)Q25][?\#_(#SO\
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MUU?\O3^O^' [+_AF/]FK_HW?X%_^&D\ _P#R@H_X9B_9J_Z-W^!?_AI/ /\
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M!1_PS'^S5_T;O\"__#2> ?\ Y05[A11R+^OE_E^('A__  S'^S5_T;O\"_\
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M^(-IIDPF^T1^,[;PEXX\*7>K32H(9+#QE"BNQBF5/J\  #:%"@#:% 4  #&
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M\&VVHWOBRQTW4=,N+.^NO#5GI%E<7=SK2V\TAMTMX)IFD $<;,0IN-^5]_\
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ME^''CG6O"'@.30O%5[XN;QEX/MK/3-0G\;:IJ]_X;TR34]1U+Q3J/B"ZEOS
MAOI;R5VM[;RPLGV%3C:VG4 HHHJ@"BBB@ HHHH **** "BBB@ HHHH ****
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M@'6=<U*R\0^+],?33(8[8_#^"6-5>XE)]<N/VT/@[;Z[HFCK;^.+JRU;P?\
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M&UWJ/P[LO'\?BO3]!N(EAO\ P>KZA!I>V$R7+7%O<7/F+'";>OK?XA0ZW<>
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M_'\'Q,\/>/O#?@SX=:[)XKU379M:L=,TO5[3PZUE<K<?98=)A6=E>U:3??\
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MD2$7#HJ-(VU2Q!QT]:II[:@%%%% !1110 4444 %%%% !1110 4444 %%%%
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M]4=$\_5XH/#W@K5((I'<QVJ6R1HJ^<=WTK7D7_#0GP!_Z+I\&>F/^2I^!?\
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3>.1&9'1PRL5(-93W]"X;OT/_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
